<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Nutr Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Nutr Sci</journal-id><journal-id journal-id-type="publisher-id">JNS</journal-id><journal-title-group><journal-title>Journal of Nutritional Science</journal-title></journal-title-group><issn pub-type="epub">2048-6790</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27313850</article-id><article-id pub-id-type="pmc">4791522</article-id><article-id pub-id-type="doi">10.1017/jns.2015.42</article-id><article-id pub-id-type="pii">S2048679015000427</article-id><article-id pub-id-type="publisher-id">00042</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Addition of a dairy fraction rich in milk fat globule membrane to a
high-saturated fat meal reduces the postprandial insulinaemic and inflammatory response in
overweight and obese adults</article-title><alt-title alt-title-type="left-running">Elieke Demmer <italic>et al</italic>.</alt-title><alt-title alt-title-type="right-running">Addition of a dairy fraction rich in milk fat
globule membrane to a high-saturated fat meal reduces the postprandial insulinaemic and
inflammatory response in overweight and obese adults</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Demmer</surname><given-names>Elieke</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Van Loan</surname><given-names>Marta D.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rivera</surname><given-names>Nancy</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rogers</surname><given-names>Tara S.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gertz</surname><given-names>Erik R.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>German</surname><given-names>J. Bruce</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Smilowitz</surname><given-names>Jennifer T.</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Zivkovic</surname><given-names>Angela M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Nutrition</addr-line>,
<institution>University of California Davis</institution>, <addr-line>Davis,
CA</addr-line>, <country>USA</country></aff><aff id="aff2"><label>2</label><institution>USDA/ARS Western Human Nutrition Research
Center</institution>, <addr-line>Davis, CA</addr-line>, <country>USA</country></aff><aff id="aff3"><label>3</label><institution>Foods for Health Institute, University of
California</institution>, <addr-line>Davis, CA</addr-line>, <country>USA</country></aff><aff id="aff4"><label>4</label><addr-line>Department of Food Science &#x00026;
Technology</addr-line>, <institution>University of California</institution>,
<addr-line>Davis, CA</addr-line>, <country>USA</country></aff><author-notes><corresp id="cor1"><label>*</label><bold>Corresponding author:</bold> A. M. Zivkovic, email
<email>amzivkovic@ucdavis.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>7</day><month>3</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e14</elocation-id><history><date date-type="received"><day>01</day><month>7</month><year>2015</year></date><date date-type="rev-recd"><day>09</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article, distributed under the terms of the Creative
Commons Attribution licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits
unrestricted re-use, distribution, and reproduction in any medium, provided the original
work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S2048679015000427a.pdf"/><abstract abstract-type="normal"><p>Meals high in SFA, particularly palmitate, are associated with postprandial inflammation
and insulin resistance. Milk fat globule membrane (MFGM) has anti-inflammatory properties
that may attenuate the negative effects of SFA-rich meals. Our objective was to examine
the postprandial metabolic and inflammatory response to a high-fat meal composed of palm
oil (PO) compared with PO with an added dairy fraction rich in MFGM (PO+MFGM) in
overweight and obese men and women (<italic>n</italic> 36) in a randomised,
double-blinded, cross-over trial. Participants consumed two isoenergetic high-fat meals
composed of a smoothie enriched with PO with <italic>v</italic>. without a cream-derived
complex milk lipid fraction ( dairy fraction rich in MFGM) separated by a washout of 1&#x02013;2
weeks. Serum cytokines, adhesion molecules, cortisol and markers of inflammation were
measured at fasting, and at 1, 3 and 6&#x000a0;h postprandially. Glucose, insulin and lipid
profiles were analysed in plasma. Consumption of the PO&#x000a0;+&#x000a0;MFGM <italic>v</italic>. PO meal
resulted in lower total cholesterol (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;021), LDL-cholesterol
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;046), soluble intracellular adhesion molecule
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;005) and insulin (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;005) incremental AUC, and
increased IL-10 (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;013). Individuals with high baseline C-reactive
protein (CRP) concentrations (&#x02265;3&#x000a0;mg/l, <italic>n</italic> 17) had higher
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;030) insulin at 1&#x000a0;h after the PO meal than individuals with CRP
concentrations &#x0003c;3&#x000a0;mg/l (<italic>n</italic> 19). The addition of MFGM attenuated
this difference between CRP groups. The addition of a dairy fraction rich in MFGM
attenuated the negative effects of a high-SFA meal by reducing postprandial cholesterol,
inflammatory markers and insulin response in overweight and obese individuals,
particularly in those with elevated CRP.</p></abstract><kwd-group><title>Key words</title><kwd>Milk fat globule membrane</kwd><kwd>Postprandial inflammation</kwd><kwd>Saturated fat</kwd><kwd>Insulin</kwd><kwd>C-reactive protein</kwd><kwd>CVD</kwd><kwd>Cytokines</kwd></kwd-group><kwd-group kwd-group-type="abbreviations"><title>Abbreviations</title><kwd>CRP, C-reactive protein</kwd><kwd>iAUC, incremental AUC</kwd><kwd>MetS, metabolic syndrome</kwd><kwd>MFGM, milk fat globule membrane</kwd><kwd>PO, palm oil</kwd><kwd>sICAM, soluble intracellular adhesion molecule</kwd></kwd-group><counts><fig-count count="4"/><table-count count="4"/><ref-count count="54"/><page-count count="11"/></counts></article-meta></front><body><p>The postprandial state has been highlighted as an important transitory period when
significant vascular damage can occur and has recently been implicated in the causal processes
of CVD<sup>(</sup><xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref><sup>)</sup>. Postprandial inflammatory and lipaemic responses are pronounced in
individuals with obesity, the metabolic syndrome (MetS) and type 2 diabetes<sup>(</sup><xref rid="ref2" ref-type="bibr">
<sup>2</sup>
</xref><sup>&#x02013;</sup><xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref><sup>)</sup>, in part because the magnitude of the postprandial inflammatory response
is correlated with insulin resistance<sup>(</sup><xref rid="ref6" ref-type="bibr">
<sup>6</sup>
</xref><sup>,</sup><xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref><sup>)</sup>. Current literature suggests that the inflammation of the postprandial
state adds to the already pro-inflammatory environment in individuals with obesity-induced
metabolic disease, intensifying the overall systemic inflammation that underlies metabolic
dysfunction<sup>(</sup><xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref><sup>)</sup>. Given the rise in overweight and obesity worldwide<sup>(</sup><xref rid="ref9" ref-type="bibr">
<sup>9</sup>
</xref><sup>)</sup>, potential nutritional interventions that can limit the postprandial
inflammatory response would be of great public health benefit.</p><p>The postprandial inflammatory response is influenced by the fat content and composition of
the test meal<sup>(</sup><xref rid="ref10" ref-type="bibr">
<sup>10</sup>
</xref><sup>&#x02013;</sup><xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref><sup>)</sup>. It has been shown that SFA induce inflammation
postprandially<sup>(</sup><xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref><sup>)</sup>. Palmitic acid in particular appears to be detrimental. The consumption of
palmitic acid acutely increases the insulin response compared with oleic acid and
<italic>n</italic>-3 fatty acids<sup>(</sup><xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref><sup>)</sup> and this was shown to be related to the adverse effects of palmitate on
both &#x003b2;-cell function and insulin sensitivity in the postprandial state<sup>(</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>)</sup>. Palmitate, either as an isolated fatty acid or as part of a high-SFA
meal, increases inflammatory markers in the postprandial state<sup>(</sup><xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref><sup>)</sup>. Palm oil (PO) is enriched in palmitate and has been used widely in the
food industry as a substitute for <italic>trans</italic>-fatty acids, which are known to have
deleterious effects on CVD risk<sup>(</sup><xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref><sup>)</sup>.</p><p>Milk fat globule membrane (MFGM) fractions have previously been reported to reduce
inflammation in <italic>in vitro</italic> and animal models<sup>(</sup><xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref><sup>&#x02013;</sup><xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref><sup>)</sup>. MFGM, a protein&#x02013;lipid complex originating from the apical surface of
mammary epithelial cells, surrounds the fat globules in milk and is found in dairy products at
varying levels. Specific proteins and lipids of MFGM are associated with health-promoting
bioactive functions. For example, one major MFGM-associated protein, lactadherin, was reported
to bind and neutralise viruses, reduce intestinal inflammation, improve intestinal
permeability, and repair intestinal epithelium<sup>(</sup><xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref><sup>,</sup><xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref><sup>&#x02013;</sup><xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref><sup>)</sup>. MFGM-derived polar lipids were reported to have bactericidal properties,
bind enterotoxigenic pathogens and reduce intestinal inflammation<sup>(</sup><xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref><sup>,</sup><xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref><sup>,</sup><xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref><sup>&#x02013;</sup><xref rid="ref27" ref-type="bibr">
<sup>27</sup>
</xref><sup>)</sup>. In addition to functions attributed to its individual components, MFGM as
a complex also reduced inflammation <italic>in vitro</italic>, in animals and
clinically<sup>(</sup><xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref><sup>,</sup><xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref><sup>,</sup><xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref><sup>)</sup>. However, it is not known whether the addition of a dairy fraction rich in
MFGM to meals high in saturated fat would blunt the postprandial inflammatory response in
human subjects.</p><p>The objective of this study was to determine the postprandial inflammatory effect of a
high-saturated fat meal using PO with and without the addition of MFGM in overweight and obese
adults. We hypothesised that consuming a high-fat PO&#x000a0;+&#x000a0;MFGM meal would result in lower
pro-inflammatory serum markers compared with the isoenergetic PO meal.</p><sec sec-type="materialsandmethods" id="sec1"><title>Materials and methods</title><sec id="sec1-1" sec-type="subjects"><title>Participants</title><p>A total of seventeen adult men and nineteen adult women (total of thirty-six
participants) were recruited from the Davis and greater Sacramento areas of California to
participate in this study. To qualify, individuals had to be between 18 and 65 years of
age, and either be overweight according to their BMI (25&#x02013;29&#x000b7;9&#x000a0;kg/m<sup>2</sup>) plus have
two or more MetS traits according to the definition of the American Heart Association or
simply be obese according to their BMI (30&#x02013;39&#x000b7;9&#x000a0;kg/m<sup>2</sup>) and have any number of
MetS traits. The MetS is defined by having three or more of the following traits: waist
circumference &#x0003e;40 inches (&#x0003e;102 cm) for men and 35 inches (&#x0003e;89 cm)
inches for women; fasting plasma TAG&#x000a0;&#x02265;&#x000a0;150&#x000a0;mg/dl (&#x02265;&#x000a0;1&#x000b7;70 mmol/l); fasting plasma
HDL-cholesterol &#x0003c;40&#x000a0;mg/dl (&#x0003c;1&#x000b7;04 mmol/l) for men and &#x0003c;50&#x000a0;mg/dl
(&#x0003c;1&#x000b7;30 mmol/l) for women; blood pressure &#x02265;130/85&#x000a0;mmHg; and fasting glucose
&#x02265;100&#x000a0;mg/dl (&#x02265;5&#x000b7;56 mmol/l)<sup>(</sup><xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref><sup>)</sup>. Individuals were excluded from participation for the following
reasons: diagnosis of immune-related diseases, gastrointestinal disorders, cancer, type 2
diabetes, eating disorder, allergies to the provided study foods, poor vein accessibility
according to the research phlebotomist, or a body-weight change greater than 10&#x000a0;% over the
past 6 months. Individuals were excluded from participation if they used the following:
weight loss medications; daily non-steroidal anti-inflammatory drugs (NSAID);
anti-inflammatory supplements; corticoid steroids; tobacco; change in hormonal birth
control regimen with the past 6 months; initiation of statins in past 3 months. Because of
possible confounding effects on inflammatory outcomes, dietary exclusion criteria were as
follows: &#x0003e;1 serving of fish/week; &#x0003e;14&#x000a0;g fibre/1000&#x000a0;kcal (4184 kJ) per d;
&#x0003c;16:1 of total dietary <italic>n</italic>-6:<italic>n</italic>-3 ratio; &#x0003e;1&#x000a0;%
of daily energy as <italic>trans</italic>-fats; and a vegetarian diet pattern. If
individuals had initiated an exercise programme within the past 6 months, planned to
become pregnant within the next 6 months, or were already pregnant or lactating, they were
not enrolled in the study. To determine enrolment eligibility, questionnaires were
administered regarding health history, diet and medication. An online FFQ was used to
assess dietary intake and a fasting blood sample was drawn for the analysis of blood
lipids and glucose. Additional anthropometric measurements were taken during the screening
visit to determine MetS traits (weight, height, and waist circumference).</p><p>This study was approved from an ethical standpoint by the Institutional Review Board of
the University of California, Davis. Informed consent was given in writing by all study
participants prior to starting the study protocol. The study was registered at
clinicaltrials.gov under NCT01811329.</p></sec><sec id="sec1-2"><title>Study design</title><p>Two isoenergetic test meals were consumed by the participants in a randomised,
double-blinded, two-way cross-over design. A high-fat PO meal was compared against a
high-fat PO meal with the addition of MFGM (PO&#x000a0;+&#x000a0;MFGM). Participants were assigned to test
meal order using a random number generator which randomly returned either a 0 or 1, with a
0 being assigned to PO first followed by PO&#x000a0;+&#x000a0;MFGM second, and a 1 being assigned to
PO&#x000a0;+&#x000a0;MFGM first followed by PO second. Test meals were consumed in random order on
different test days separated by a washout phase of minimally 1 week and maximally 2 weeks
to avoid any carry-over effects. After each washout, participants consumed the alternate
test meal.</p><p>To limit confounding effects, the consumption of anti-inflammatory supplements, alcohol
or NSAID was not permitted for 72 h before each test day. At 24 h prior to the test day,
vigorous exercise was prohibited to avoid increasing inflammatory markers and conversely
consumption of seafood was not allowed to avoid a suppression of inflammatory markers. To
ensure compliance, participants filled out a 1-d food record for the 24&#x000a0;h prior to each
test day. The dietary records were analysed using the Nutrition Data System for Research
(NDSR; University of Minnesota).</p><p>Participants arrived at the Western Human Nutrition Research Center after a 10&#x02013;12&#x000a0;h fast
on each test day. The 24&#x000a0;h diet record was collected and participants were asked to
complete a modified gastrointestinal questionnaire<sup>(</sup><xref rid="ref30" ref-type="bibr">
<sup>30</sup>
</xref><sup>)</sup>. A fasted blood sample was drawn via venepuncture. Blood pressure,
heart rate, weight and waist circumference were measured. The dietary test meal was then
consumed completely within 20&#x000a0;min. Postprandial blood draws were conducted at 1, 3 and
6&#x000a0;h. These time points were determined based on previous postprandial clinical trials
observing a peak in pro-inflammatory cytokine concentrations around 3&#x02013;6&#x000a0;h after consuming
a high-fat meal<sup>(</sup><xref rid="ref6" ref-type="bibr">
<sup>6</sup>
</xref><sup>,</sup><xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref><sup>)</sup>.</p><p>Consumption of any food other than the test meal was not permitted, but bottled water was
offered throughout the test day. Participants were offered the option to stay at the
research facility or leave between blood draws via car to limit physical activity and had
to return 15&#x000a0;min before their scheduled blood draw to allow for a 10&#x000a0;min rest period prior
to each blood draw.</p></sec><sec id="sec1-3"><title>Dietary challenges</title><p>The two test meals were made up of a bagel with strawberry preserves along with either a
PO or PO&#x000a0;+&#x000a0;MFGM smoothie. In each instance the smoothie consisted of deionised water,
cream of tartar, PO shortening, and raspberry sorbet. Additionally, the PO&#x000a0;+&#x000a0;MFGM smoothie
contained BPC50, a cream-derived complex milk lipid fraction powder (&#x003b2; serum concentrate)
that is a proprietary product supplied by Fonterra Co-operative Group Ltd (New
Zealand)<sup>(</sup><xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref><sup>)</sup>. BPC50 is comprised of the following (%&#x000a0;w/w): 52&#x000a0;% protein of which
13&#x000b7;2&#x000a0;% is membrane-derived protein, 6&#x000b7;6&#x000a0;% lactose and 36&#x000b7;2&#x000a0;% total fat (22&#x000b7;5&#x000a0;% TAG and
13&#x000b7;7&#x000a0;% phospholipids), 0&#x000b7;63&#x000a0;% gangliosides (GD3), and 5&#x000b7;2&#x000a0;% ash<sup>(</sup><xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref><sup>&#x02013;</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>)</sup>. The six highest abundant MFGM-derived proteins reported in BPC50
include: fatty acid-binding protein, butyrophilin, lactadherin, adipophilin, xanthine
oxidase and mucin<sup>(</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>)</sup>. The PO smoothie contained whey protein isolate to match the protein
content found in the BPC50 product. For ingredient details, see Supplementary Table S1.
Participants were instructed to eat the entire meal, rinse their cup with water, and drink
the rinse-water.</p><p>Each test meal provided 40&#x000a0;% of the participant's total daily energy intake. Energy
intake was determined by using the National Academy of Sciences equation from the
Institute of Medicine Dietary Reference Intake<sup>(</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>)</sup>. To determine each participant's physical activity level the Baecke
Physical Activity questionnaire was used<sup>(</sup><xref rid="ref37" ref-type="bibr">
<sup>37</sup>
</xref><sup>)</sup>.</p><p>The two isoenergetic test meals were constructed to vary less than 0&#x000b7;2&#x000a0;% in
macronutrients and provided about 55&#x000a0;% fat, about 30&#x000a0;% carbohydrates, and about 15&#x000a0;%
protein. Each test meal provided between 49 and 87&#x000a0;g of fat depending on each individual's
energy intake, 61&#x02013;107&#x000a0;g of carbohydrates, and 31&#x02013;55&#x000a0;g of protein (<xref ref-type="table" rid="tab01">Table 1</xref>). Test meal nutrient composition was estimated using NDSR
(University of Minnesota). The addition of MFGM (ranging from 53&#x000b7;2 to 93&#x000b7;1&#x000a0;g depending on
each individual's energy intake) replaced 31&#x000a0;% of the fat of each participant's meal (34&#x000a0;%
of the total energy). <table-wrap id="tab01" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Nutrient composition of test meals<xref ref-type="table-fn" rid="tfn1_3">&#x02020;</xref></p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679015000427_tab1"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">PO meal</th><th align="center" colspan="2" rowspan="1">PO&#x000a0;+&#x000a0;MFGM meal</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Energy (kcal)</td><td rowspan="1" colspan="1">1088&#x000b7;1</td><td rowspan="1" colspan="1">189&#x000b7;3</td><td rowspan="1" colspan="1">1088&#x000b7;1</td><td rowspan="1" colspan="1">189&#x000b7;2</td></tr><tr><td rowspan="1" colspan="1">Energy (kJ)</td><td rowspan="1" colspan="1">4552&#x000b7;4</td><td rowspan="1" colspan="1">791&#x000b7;8</td><td rowspan="1" colspan="1">4552&#x000b7;7</td><td rowspan="1" colspan="1">791&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">Total carbohydrate</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;g</td><td rowspan="1" colspan="1">82&#x000b7;7</td><td rowspan="1" colspan="1">14&#x000b7;4</td><td rowspan="1" colspan="1">83&#x000b7;2</td><td rowspan="1" colspan="1">14&#x000b7;5</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;% total energy</td><td rowspan="1" colspan="1">30&#x000b7;4</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">30&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Total protein</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;g</td><td rowspan="1" colspan="1">42&#x000b7;5</td><td rowspan="1" colspan="1">7&#x000b7;4</td><td rowspan="1" colspan="1">43</td><td rowspan="1" colspan="1">7&#x000b7;5</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;% total energy</td><td rowspan="1" colspan="1">15&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">15&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Total fat</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;g</td><td rowspan="1" colspan="1">67&#x000b7;3</td><td rowspan="1" colspan="1">11&#x000b7;7</td><td rowspan="1" colspan="1">67&#x000b7;5</td><td rowspan="1" colspan="1">11&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;% total energy</td><td rowspan="1" colspan="1">55&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">55&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Total SFA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;g</td><td rowspan="1" colspan="1">32&#x000b7;6</td><td rowspan="1" colspan="1">5&#x000b7;7</td><td rowspan="1" colspan="1">34&#x000b7;6</td><td rowspan="1" colspan="1">6&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;% total energy</td><td rowspan="1" colspan="1">27&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">28&#x000b7;6</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Total MUFA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;g</td><td rowspan="1" colspan="1">24&#x000b7;6</td><td rowspan="1" colspan="1">4&#x000b7;3</td><td rowspan="1" colspan="1">22&#x000b7;7</td><td rowspan="1" colspan="1">3&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;% total energy</td><td rowspan="1" colspan="1">20&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">18&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Total PUFA<xref ref-type="table-fn" rid="tfn1_2">*</xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;g</td><td rowspan="1" colspan="1">6&#x000b7;9</td><td rowspan="1" colspan="1">1&#x000b7;2</td><td rowspan="1" colspan="1">6&#x000b7;1</td><td rowspan="1" colspan="1">1&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;% total energy</td><td rowspan="1" colspan="1">5&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">5&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 4 : 0 (butyric acid) (%)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 6 : 0 (caproic acid) (%)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 8 : 0 (caprylic acid) (%)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">SFA 10 : 0 (capric acid) (%)<xref ref-type="table-fn" rid="tfn1_2">*</xref></td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">SFA 12 : 0 (lauric acid) (%)<xref ref-type="table-fn" rid="tfn1_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;8</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">SFA 14 : 0 (myristic acid) (%)<xref ref-type="table-fn" rid="tfn1_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">2&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">SFA 16 : 0 (palmitic acid) (%)<xref ref-type="table-fn" rid="tfn1_2">*</xref></td><td rowspan="1" colspan="1">28&#x000b7;7</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">24&#x000b7;8</td><td rowspan="1" colspan="1">4&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1">SFA 18 : 0 (stearic acid) (%)<xref ref-type="table-fn" rid="tfn1_2">*</xref></td><td rowspan="1" colspan="1">2&#x000b7;9</td><td rowspan="1" colspan="1">0&#x000b7;5</td><td rowspan="1" colspan="1">4&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;8</td></tr><tr><td rowspan="1" colspan="1">MUFA 16 : 1 (palmitoleic acid) (%)<xref ref-type="table-fn" rid="tfn1_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;2</td><td rowspan="1" colspan="1">0&#x000b7;0</td><td rowspan="1" colspan="1">0&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">MUFA 18 : 1 (oleic acid) (%)<xref ref-type="table-fn" rid="tfn1_2">*</xref></td><td rowspan="1" colspan="1">24&#x000b7;3</td><td rowspan="1" colspan="1">4&#x000b7;2</td><td rowspan="1" colspan="1">22&#x000b7;2</td><td rowspan="1" colspan="1">3&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">PUFA 18 : 2 (linoleic acid) (%)</td><td rowspan="1" colspan="1">6&#x000b7;6</td><td rowspan="1" colspan="1">1&#x000b7;1</td><td rowspan="1" colspan="1">5&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">PUFA 18 : 3 (linolenic acid) (%)</td><td rowspan="1" colspan="1">0&#x000b7;3</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">0&#x000b7;5</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>PO, palm oil; PO&#x000a0;+&#x000a0;MFGM, palm oil&#x000a0;+&#x000a0;milk fat globule membrane.</p></fn><fn id="tfn1_2"><label>*</label><p>Significant difference between the two meals
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn><fn id="tfn1_3"><label>&#x02020;</label><p>Comparison of the dietary challenges. Nutrient composition obtained using the
Nutrition Data System for Research (NDSR). Test meals were based on each
individual's total energy expenditure; thus values shown are average of all test
meals (<italic>n</italic> 36).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec1-4"><title>Blood analyses</title><p>Whole blood was drawn at baseline, and at 1, 3 and 6&#x000a0;h after the meal. Serum tubes were
allowed to clot at room temperature for 30&#x000a0;min, and then centrifuged at 1300&#x000a0;<bold><italic>g</italic></bold> at 4&#x000b0;C for 10&#x000a0;min. EDTA-whole blood tubes were kept on ice during and after blood
collection and were centrifuged within 30&#x000a0;min of collection at 1300&#x000a0;<bold><italic>g</italic></bold> at 4&#x000b0;C for 10&#x000a0;min. After centrifugation, the serum and plasma tubes were kept on
ice during aliquoting. Subsequently, plasma and serum aliquots were directly frozen at
&#x02013;70&#x000b0;C until analysed.</p></sec><sec id="sec1-5"><title>Inflammatory markers</title><p>Serum samples from all four time points were analysed for cytokine concentrations (IL-10,
IL-1&#x003b2;, IL-2, IL-4, IL-6, IL-8, TNF&#x003b1;, monocyte chemotactic protein-1), as well as the
vascular injury molecules C-reactive protein (CRP), serum amyloid A, soluble intracellular
adhesion molecule (sICAM) and soluble vascular adhesion molecule. Plasma was used to
measure IL-18 concentrations. A commercially available Multi Spot ELISA kit was used to
quantify the concentrations of these markers (SECTOR Imager 2400; Meso Scale Discovery).
The protocol was followed as recommended by the manufacturer. Briefly, pre-coated plates
with capture antibodies were incubated with 25&#x02013;50&#x000a0;&#x000b5;l of serum or plasma. After washing the
plates a labelled detection antibody was added. Upon electrochemical stimulation the bound
detection antibodies emit light, which is measured by the plate reader to quantify the
amount of each protein of interest.</p></sec><sec id="sec1-6"><title>Cortisol</title><p>Serum cortisol was measured at all times points using the DetectX Cortisol Enzyme
Immunoassay kit (Arbor Assays). Briefly, a cortisol&#x02013;peroxidase conjugate and a monoclonal
cortisol antibody were added to a pre-coated ninety-six-well plate. Upon incubation, serum
samples were added to each well and allowed to bind with the cortisol&#x02013;peroxidase
conjugate. The total amount of cortisol present in each sample was then calculated based
on the absorbance detected by the reader.</p></sec><sec id="sec1-7"><title>Metabolic parameters</title><p>At each time point plasma glucose, insulin, and a lipid panel including TAG, total
cholesterol, HDL-cholesterol, LDL-cholesterol, HDL:LDL ratio, and non-HDL-cholesterol were
assessed by standard clinical techniques in the clinical laboratory of University of
California Medical Center (Sacramento, CA).</p></sec><sec id="sec1-8"><title>Clinical characteristics</title><p>Body weight, height, waist circumference, blood pressure and heart rate were measured on
each test day. Body weight was measured with a calibrated scale (6002 Wheelchair Scale;
Scale-tronix). Waist circumference was measured in the standing position with measurements
midway between the lateral lower rib margin and the ileac crest (QM2000 Measure Mate;
QuickMedical). Height was measured with a wall-mounted stadiometer (Ayrton Stadiometer
Model S100; Ayrton Corporation). Blood pressure and resting heart rate were taken in the
upright seated position using the appropriately sized cuff (Carescape V100 with Critikon
Dura-cuf for either adults or large adults; GE Medical Instruments). Total fat mass and
lean mass were assessed using dual-energy X-ray absorptiometry (Lunar Prodigy instrument;
GE Medical Instruments).</p></sec><sec id="sec1-9"><title>Statistical analysis</title><p>The sample size was calculated based on the primary outcome marker IL-6 using the means
and standard deviations from a similar human study with overweight men at risk for
developing the MetS<sup>(</sup><xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref><sup>)</sup>. To ensure 95&#x000a0;% confidence of the results and 80&#x000a0;% power the sample
size calculation indicated that thirty-six participants would be needed.</p><p>Statistical analyses were conducted on SPSS version 20.0 software for Macintosh (SPSS).
Differences were considered significant at <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05. Normality was
established visually and numerically using histograms, Q&#x02013;Q plots and the Shapiro&#x02013;Wilk
test. Data were transformed as needed. When concentrations for markers were below the
lower limit of detection (LLOD) (IL-10; 23&#x000a0;% and IL-6; 9&#x000a0;%) for &#x0003c;25&#x000a0;% of the
samples, the value was calculated as the LLOD divided by 10. When concentrations for
markers were below the LLOD for &#x0003e;25&#x000a0;% of the samples, the data were excluded from
statistical analyses (IL-1&#x003b2; and IL-4). Cases with values more than three box lengths from
the 75th percentile or 25th percentile were deemed outliers and removed from all analyses;
this only applied to sICAM where two subjects were excluded.</p><p>To determine if dietary differences existed between test meal composition and baseline
analyte concentrations a paired <italic>t</italic> test was used. A mixed linear model was
performed with treatment and time as fixed factors, participants as the random effect and
treatment&#x000a0;&#x000d7;&#x000a0;time as the interaction term. If time was significant, multiple-comparison
<italic>post hoc</italic> analysis with Bonferroni correction was carried out to compare
the concentrations at 0&#x02013;1&#x000a0;h, 0&#x02013;3&#x000a0;h, 0&#x02013;6&#x000a0;h, 1&#x02013;3&#x000a0;h, 1&#x02013;6&#x000a0;h, and 3&#x02013;6&#x000a0;h.</p><p>The incremental AUC (iAUC, area above baseline) and decremental (area below baseline)
using the conventional trapezoid method were used to compare postprandial responses
between test meals<sup>(</sup><xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref><sup>)</sup>. The iAUC was chosen over the total AUC because it reflects the
postprandial rise of these metabolite concentrations above the non-zero fasting
value<sup>(</sup><xref rid="ref39" ref-type="bibr">
<sup>39</sup>
</xref><sup>)</sup>. iAUC between test meals were compared by one-way ANOVA.</p><p>To determine if pre-existing clinical conditions affected the inflammatory responses to
the test meals, secondary analyses were conducted. Participants were coded as having high
or low CRP levels based on their baseline levels prior to receiving either test meal
treatment. High CRP was defined as a concentration &#x02265;3&#x000a0;mg/l (<italic>n</italic> 17), low
CRP was defined as &#x0003c;3&#x000a0;mg/l (<italic>n</italic> 19)<sup>(</sup><xref rid="ref40" ref-type="bibr">
<sup>40</sup>
</xref><sup>)</sup>. Baseline characteristics of each CRP group can be found in <xref ref-type="table" rid="tab02">Table 2</xref>. ANCOVA was used to identify statistically
significant differences in postprandial inflammatory markers between test meals using CRP
as the covariate variable. <table-wrap id="tab02" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Participant baseline characteristics<xref ref-type="table-fn" rid="tfn2_2">*</xref></p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679015000427_tab2"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">All participants</th><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Low CRP<xref ref-type="table-fn" rid="tfn2_4">&#x02021;</xref></th><th align="center" colspan="2" rowspan="1">High CRP<xref ref-type="table-fn" rid="tfn2_4">&#x02021;</xref></th></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">MetS criteria<xref ref-type="table-fn" rid="tfn2_3">&#x02020;</xref></th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">42&#x000b7;9</td><td rowspan="1" colspan="1">14&#x000b7;0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">42&#x000b7;4</td><td rowspan="1" colspan="1">13&#x000b7;6</td><td rowspan="1" colspan="1">43&#x000b7;6</td><td rowspan="1" colspan="1">14&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">Weight (kg)</td><td rowspan="1" colspan="1">92&#x000b7;9</td><td rowspan="1" colspan="1">12&#x000b7;2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">93&#x000b7;5</td><td rowspan="1" colspan="1">11&#x000b7;9</td><td rowspan="1" colspan="1">92&#x000b7;2</td><td rowspan="1" colspan="1">12&#x000b7;8</td></tr><tr><td rowspan="1" colspan="1">Height (m)</td><td rowspan="1" colspan="1">1&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;1</td><td rowspan="1" colspan="1">1&#x000b7;7</td><td rowspan="1" colspan="1">0&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">31&#x000b7;7</td><td rowspan="1" colspan="1">2&#x000b7;6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">31&#x000b7;9</td><td rowspan="1" colspan="1">2&#x000b7;6</td><td rowspan="1" colspan="1">31&#x000b7;5</td><td rowspan="1" colspan="1">2&#x000b7;5</td></tr><tr><td rowspan="1" colspan="1">Total body fat (%)</td><td rowspan="1" colspan="1">36&#x000b7;7</td><td rowspan="1" colspan="1">7&#x000b7;8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">34&#x000b7;2</td><td rowspan="1" colspan="1">8&#x000b7;3</td><td rowspan="1" colspan="1">39&#x000b7;5</td><td rowspan="1" colspan="1">6&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Total body fat, male (%)<xref ref-type="table-fn" rid="tfn2_5">&#x000a7;</xref></td><td rowspan="1" colspan="1">31&#x000b7;0</td><td rowspan="1" colspan="1">6&#x000b7;2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">28&#x000b7;5</td><td rowspan="1" colspan="1">4&#x000b7;3</td><td rowspan="1" colspan="1">35&#x000b7;5</td><td rowspan="1" colspan="1">6&#x000b7;8</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Total body fat, female (%)<xref ref-type="table-fn" rid="tfn2_5">&#x000a7;</xref></td><td rowspan="1" colspan="1">41&#x000b7;9</td><td rowspan="1" colspan="1">4&#x000b7;9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">42&#x000b7;1</td><td rowspan="1" colspan="1">5&#x000b7;1</td><td rowspan="1" colspan="1">41&#x000b7;7</td><td rowspan="1" colspan="1">5&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">Android fat (g)</td><td rowspan="1" colspan="1">3262&#x000b7;9</td><td rowspan="1" colspan="1">799&#x000b7;9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">40&#x000b7;5</td><td rowspan="1" colspan="1">6&#x000b7;7</td><td rowspan="1" colspan="1">46&#x000b7;1</td><td rowspan="1" colspan="1">4&#x000b7;2</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Android fat, male (g)</td><td rowspan="1" colspan="1">3370&#x000b7;8</td><td rowspan="1" colspan="1">934&#x000b7;1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">37&#x000b7;2</td><td rowspan="1" colspan="1">5&#x000b7;7</td><td rowspan="1" colspan="1">45&#x000b7;2</td><td rowspan="1" colspan="1">3&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Android fat, female (g)</td><td rowspan="1" colspan="1">3166&#x000b7;3</td><td rowspan="1" colspan="1">669&#x000b7;0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">45&#x000b7;0</td><td rowspan="1" colspan="1">5&#x000b7;3</td><td rowspan="1" colspan="1">46&#x000b7;7</td><td rowspan="1" colspan="1">4&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">Gynoid fat (g)</td><td rowspan="1" colspan="1">5353&#x000b7;3</td><td rowspan="1" colspan="1">1452&#x000b7;0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">36&#x000b7;9</td><td rowspan="1" colspan="1">8&#x000b7;6</td><td rowspan="1" colspan="1">39&#x000b7;5</td><td rowspan="1" colspan="1">7&#x000b7;0</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Gynoid fat, male (g)</td><td rowspan="1" colspan="1">4829&#x000b7;2</td><td rowspan="1" colspan="1">1325&#x000b7;8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">31&#x000b7;2</td><td rowspan="1" colspan="1">5&#x000b7;0</td><td rowspan="1" colspan="1">33&#x000b7;5</td><td rowspan="1" colspan="1">5&#x000b7;3</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;Gynoid fat, female (g)</td><td rowspan="1" colspan="1">5822&#x000b7;1</td><td rowspan="1" colspan="1">1430&#x000b7;2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">44&#x000b7;8</td><td rowspan="1" colspan="1">5&#x000b7;7</td><td rowspan="1" colspan="1">42&#x000b7;7</td><td rowspan="1" colspan="1">5&#x000b7;6</td></tr><tr><td rowspan="1" colspan="1">WC (inches)</td><td rowspan="1" colspan="1">39&#x000b7;3</td><td rowspan="1" colspan="1">3&#x000b7;2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">38&#x000b7;8</td><td rowspan="1" colspan="1">2&#x000b7;9</td><td rowspan="1" colspan="1">39&#x000b7;9</td><td rowspan="1" colspan="1">3&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;WC, male (inches)</td><td rowspan="1" colspan="1">41&#x000b7;1</td><td rowspan="1" colspan="1">3&#x000b7;1</td><td rowspan="1" colspan="1">&#x0003e;40</td><td rowspan="1" colspan="1">40&#x000b7;2</td><td rowspan="1" colspan="1">2&#x000b7;9</td><td rowspan="1" colspan="1">42&#x000b7;8</td><td rowspan="1" colspan="1">2&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;WC, female (inches)</td><td rowspan="1" colspan="1">37&#x000b7;7</td><td rowspan="1" colspan="1">2&#x000b7;2</td><td rowspan="1" colspan="1">&#x0003e;35</td><td rowspan="1" colspan="1">36&#x000b7;9</td><td rowspan="1" colspan="1">1&#x000b7;6</td><td rowspan="1" colspan="1">38&#x000b7;2</td><td rowspan="1" colspan="1">2&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">WC (cm)</td><td rowspan="1" colspan="1">99&#x000b7;8</td><td rowspan="1" colspan="1">8&#x000b7;1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">98&#x000b7;6</td><td rowspan="1" colspan="1">7&#x000b7;4</td><td rowspan="1" colspan="1">101&#x000b7;3</td><td rowspan="1" colspan="1">8&#x000b7;6</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;WC, male (cm)</td><td rowspan="1" colspan="1">104&#x000b7;4</td><td rowspan="1" colspan="1">7&#x000b7;9</td><td rowspan="1" colspan="1">&#x0003e;102</td><td rowspan="1" colspan="1">102&#x000b7;1</td><td rowspan="1" colspan="1">7&#x000b7;4</td><td rowspan="1" colspan="1">108&#x000b7;7</td><td rowspan="1" colspan="1">7&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;WC, female (cm)</td><td rowspan="1" colspan="1">95&#x000b7;8</td><td rowspan="1" colspan="1">5&#x000b7;6</td><td rowspan="1" colspan="1">&#x0003e;89</td><td rowspan="1" colspan="1">93&#x000b7;7</td><td rowspan="1" colspan="1">4&#x000b7;1</td><td rowspan="1" colspan="1">97&#x000b7;0</td><td rowspan="1" colspan="1">6&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">Systolic BP (mmHg)</td><td rowspan="1" colspan="1">123&#x000b7;9</td><td rowspan="1" colspan="1">13&#x000b7;6</td><td rowspan="1" colspan="1">&#x02265;130</td><td rowspan="1" colspan="1">123&#x000b7;1</td><td rowspan="1" colspan="1">9&#x000b7;5</td><td rowspan="1" colspan="1">124&#x000b7;8</td><td rowspan="1" colspan="1">17&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">Diastolic BP (mmHg)</td><td rowspan="1" colspan="1">75&#x000b7;0</td><td rowspan="1" colspan="1">10&#x000b7;3</td><td rowspan="1" colspan="1">&#x02265;85</td><td rowspan="1" colspan="1">76&#x000b7;0</td><td rowspan="1" colspan="1">9&#x000b7;2</td><td rowspan="1" colspan="1">73&#x000b7;9</td><td rowspan="1" colspan="1">11&#x000b7;6</td></tr><tr><td rowspan="1" colspan="1">HDL-cholesterol</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;mg/dl</td><td rowspan="1" colspan="1">48&#x000b7;3</td><td rowspan="1" colspan="1">14&#x000b7;1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">48&#x000b7;4</td><td rowspan="1" colspan="1">14&#x000b7;2</td><td rowspan="1" colspan="1">48&#x000b7;2</td><td rowspan="1" colspan="1">14&#x000b7;4</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;mmol/l</td><td rowspan="1" colspan="1">1&#x000b7;25</td><td rowspan="1" colspan="1">0&#x000b7;37</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1&#x000b7;25</td><td rowspan="1" colspan="1">0&#x000b7;37</td><td rowspan="1" colspan="1">1&#x000b7;25</td><td rowspan="1" colspan="1">0&#x000b7;37</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;HDL-cholesterol, male</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;mg/dl</td><td rowspan="1" colspan="1">43&#x000b7;2</td><td rowspan="1" colspan="1">11&#x000b7;7</td><td rowspan="1" colspan="1">&#x0003c;40</td><td rowspan="1" colspan="1">42&#x000b7;5</td><td rowspan="1" colspan="1">13&#x000b7;7</td><td rowspan="1" colspan="1">44&#x000b7;5</td><td rowspan="1" colspan="1">7&#x000b7;8</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;mmol/l</td><td rowspan="1" colspan="1">1&#x000b7;12</td><td rowspan="1" colspan="1">0&#x000b7;30</td><td rowspan="1" colspan="1">&#x0003c;1&#x000b7;04</td><td rowspan="1" colspan="1">1&#x000b7;10</td><td rowspan="1" colspan="1">0&#x000b7;35</td><td rowspan="1" colspan="1">1&#x000b7;15</td><td rowspan="1" colspan="1">0&#x000b7;20</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;HDL-cholesterol, female</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;mg/dl</td><td rowspan="1" colspan="1">52&#x000b7;9</td><td rowspan="1" colspan="1">14&#x000b7;7</td><td rowspan="1" colspan="1">&#x0003c;50</td><td rowspan="1" colspan="1">56&#x000b7;5</td><td rowspan="1" colspan="1">10&#x000b7;9</td><td rowspan="1" colspan="1">50&#x000b7;3</td><td rowspan="1" colspan="1">16&#x000b7;9</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;mmol/l</td><td rowspan="1" colspan="1">1&#x000b7;37</td><td rowspan="1" colspan="1">0&#x000b7;38</td><td rowspan="1" colspan="1">&#x0003c;1&#x000b7;30</td><td rowspan="1" colspan="1">1&#x000b7;46</td><td rowspan="1" colspan="1">0&#x000b7;28</td><td rowspan="1" colspan="1">1&#x000b7;30</td><td rowspan="1" colspan="1">0&#x000b7;44</td></tr><tr><td rowspan="1" colspan="1">Fasting glucose</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;mg/dl</td><td rowspan="1" colspan="1">91&#x000b7;0</td><td rowspan="1" colspan="1">7&#x000b7;4</td><td rowspan="1" colspan="1">&#x02265;100</td><td rowspan="1" colspan="1">92&#x000b7;0</td><td rowspan="1" colspan="1">7&#x000b7;8</td><td rowspan="1" colspan="1">89&#x000b7;9</td><td rowspan="1" colspan="1">7&#x000b7;1</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;mmol/l</td><td rowspan="1" colspan="1">5&#x000b7;06</td><td rowspan="1" colspan="1">0&#x000b7;41</td><td rowspan="1" colspan="1">&#x02265;5&#x000b7;56</td><td rowspan="1" colspan="1">5&#x000b7;11</td><td rowspan="1" colspan="1">0&#x000b7;43</td><td rowspan="1" colspan="1">4&#x000b7;99</td><td rowspan="1" colspan="1">0&#x000b7;39</td></tr><tr><td rowspan="1" colspan="1">Fasting TAG</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;mg/dl</td><td rowspan="1" colspan="1">122&#x000b7;5</td><td rowspan="1" colspan="1">57&#x000b7;8</td><td rowspan="1" colspan="1">&#x02265;150</td><td rowspan="1" colspan="1">106&#x000b7;0</td><td rowspan="1" colspan="1">41&#x000b7;1</td><td rowspan="1" colspan="1">140&#x000b7;9</td><td rowspan="1" colspan="1">68&#x000b7;7</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;mmol/l</td><td rowspan="1" colspan="1">1&#x000b7;38</td><td rowspan="1" colspan="1">0&#x000b7;65</td><td rowspan="1" colspan="1">&#x02265;1&#x000b7;70</td><td rowspan="1" colspan="1">1&#x000b7;20</td><td rowspan="1" colspan="1">0&#x000b7;46</td><td rowspan="1" colspan="1">1&#x000b7;59</td><td rowspan="1" colspan="1">0&#x000b7;78</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>MetS, metabolic syndrome; CRP, C-reactive protein; WC, waist circumference; BP,
blood pressure.</p></fn><fn id="tfn2_2"><label>*</label><p>Measurements taken at screening visit (<italic>n</italic> 36).</p></fn><fn id="tfn2_3"><label>&#x02020;</label><p>MetS as defined by the American Heart Association.</p></fn><fn id="tfn2_4"><label>&#x02021;</label><p>Low baseline CRP <italic>n</italic> 19; high baseline CRP <italic>n</italic>
17.</p></fn><fn id="tfn2_5"><label>&#x000a7;</label><p>Male <italic>n</italic> 17, female <italic>n</italic> 19.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec sec-type="results" id="sec2"><title>Results</title><sec id="sec2-1"><title>Participant characteristics</title><p>After screening 207 participants, thirty-eight were enrolled to start the study (<xref ref-type="fig" rid="fig01">Fig. 1</xref>). Thirty-six participants completed both
postprandial test days. The two participants who did not finish the trial were
disqualified due to scheduling difficulties and the initiation of medication that could
confound the results. Each participant was randomly assigned to one test meal and after a
1- to 2-week washout period, they were crossed-over to the alternate test meal. The
majority of the study population was Caucasian (67&#x000a0;%) or Hispanic (28&#x000a0;%). Out of the total
thirty-six participants, six were overweight with two MetS traits, three were overweight
with three or more MetS traits, twenty-one were obese with zero to two MetS traits, and
six were obese with three MetS traits. The baseline characteristics of the participants
are shown in <xref ref-type="table" rid="tab02">Table 2</xref>. <fig id="fig01" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>Enrolment and follow-up of participants in the randomised cross-over trial. PO,
palm oil; PO&#x000a0;+&#x000a0;MFGM, palm oil&#x000a0;+&#x000a0;milk fat globule membrane.</p></caption><graphic xlink:href="S2048679015000427_fig1"/></fig></p></sec><sec id="sec2-2"><title>Dietary challenge</title><p>Participants consumed two test meals, a high-fat PO test meal and a high-fat PO&#x000a0;+&#x000a0;MFGM
test meal. The meals (<xref ref-type="table" rid="tab01">Table 1</xref>) were isoenergetic
and comparable for macronutrient composition, not varying by more than 0&#x000b7;2% for
carbohydrates, protein or fat. The total weight of SFA and MUFA did not differ between the
PO <italic>v</italic>. PO&#x000a0;+&#x000a0;MFGM test meals. However, the PO meal contained a
significantly higher total amount of PUFA compared with the PO&#x000a0;+&#x000a0;MFGM test meal. The
relative abundance of 18 : 2<italic>n</italic>-6 was not significantly different between
the two test meals; however, since 18 : 2<italic>n</italic>-6 is the predominant PUFA in
the two meals, and since the PO meal had higher total PUFA, the PO meal had a higher total
amount of 18 : 2<italic>n</italic>-6. The relative abundances of specific SFA and MUFA
were significantly different: the PO&#x000a0;+&#x000a0;MFGM meal had more 10 : 0, 12 : 0, 14 : 0, 18 : 0
and 18 : 1<italic>n</italic>-9 whereas the PO meal had more 16 : 0 and 16 :
1<italic>n</italic>-7. These differences in relative abundances of fatty acids are
reflective of the composition of PO, which is enriched in palmitate (16 : 0), and MFGM,
which is enriched in medium-chain SFA characteristic of dairy fat.</p></sec><sec id="sec2-3"><title>Metabolic parameters</title><p>There was a time&#x000a0;&#x000d7;&#x000a0;treatment interaction for total cholesterol
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;04), HDL-cholesterol (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;01), TAG
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005), non-HDL-cholesterol (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;04) and
insulin (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005) (<xref ref-type="table" rid="tab03">Table
3</xref>). Among these lipid makers, the greater change in total cholesterol was observed
in response to the PO test meal; there was a 5&#x000a0;% increase from 0 to 1&#x000a0;h as well as from 0
to 6&#x000a0;h. HDL-cholesterol increased from 0 to 1&#x000a0;h by 4&#x000a0;% and decreased from 1 to 3&#x000a0;h by 4&#x000a0;%
in response to the PO test meal. In response to the PO&#x000a0;+&#x000a0;MFGM test meal, TAG concentration
increased by 104&#x000a0;% from 0 to 3&#x000a0;h and non-HDL-cholesterol concentration increased by 22&#x000a0;%
from 0 to 1&#x000a0;h. <table-wrap id="tab03" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Concentrations of metabolic markers with significant interaction effects</p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679015000427_tab3"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="8" rowspan="1">Time point</th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">0&#x000a0;h</th><th align="center" colspan="2" rowspan="1">1&#x000a0;h</th><th align="center" colspan="2" rowspan="1">3&#x000a0;h</th><th align="center" colspan="2" rowspan="1">6&#x000a0;h</th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Time&#x000a0;&#x000d7;&#x000a0;treatment:
<italic>P</italic></th></tr></thead><tbody><tr><td colspan="9" rowspan="1">Total cholesterol (mg/dl)</td><td rowspan="1" colspan="1">0&#x000b7;04</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">194&#x000b7;9</td><td rowspan="1" colspan="1">38&#x000b7;5</td><td rowspan="1" colspan="1">204&#x000b7;2<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">40&#x000b7;8</td><td rowspan="1" colspan="1">201&#x000b7;4<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">39&#x000b7;9</td><td rowspan="1" colspan="1">203&#x000b7;9<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">39&#x000b7;6</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">198&#x000b7;7</td><td rowspan="1" colspan="1">37&#x000b7;6</td><td rowspan="1" colspan="1">199&#x000b7;7</td><td rowspan="1" colspan="1">37&#x000b7;6</td><td rowspan="1" colspan="1">207&#x000b7;1</td><td rowspan="1" colspan="1">37&#x000b7;4</td><td rowspan="1" colspan="1">203&#x000b7;7</td><td rowspan="1" colspan="1">35&#x000b7;8</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Total cholesterol (mmol/l)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0&#x000b7;04</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">5&#x000b7;05</td><td rowspan="1" colspan="1">1&#x000b7;00</td><td rowspan="1" colspan="1">5&#x000b7;29<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">1&#x000b7;06</td><td rowspan="1" colspan="1">5&#x000b7;22<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">1&#x000b7;03</td><td rowspan="1" colspan="1">5&#x000b7;28<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">1&#x000b7;03</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">5&#x000b7;15</td><td rowspan="1" colspan="1">0&#x000b7;97</td><td rowspan="1" colspan="1">5&#x000b7;17</td><td rowspan="1" colspan="1">0&#x000b7;97</td><td rowspan="1" colspan="1">5&#x000b7;36</td><td rowspan="1" colspan="1">0&#x000b7;97</td><td rowspan="1" colspan="1">5&#x000b7;28</td><td rowspan="1" colspan="1">0&#x000b7;93</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="9" rowspan="1">HDL-cholesterol (mg/dl)</td><td rowspan="1" colspan="1">0&#x000b7;01</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">49&#x000b7;6</td><td rowspan="1" colspan="1">14&#x000b7;5</td><td rowspan="1" colspan="1">51&#x000b7;6<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">15&#x000b7;3</td><td rowspan="1" colspan="1">49&#x000b7;3<xref ref-type="table-fn" rid="tfn3_3">&#x02020;</xref></td><td rowspan="1" colspan="1">15&#x000b7;3</td><td rowspan="1" colspan="1">49&#x000b7;9<xref ref-type="table-fn" rid="tfn3_3">&#x02020;</xref></td><td rowspan="1" colspan="1">15&#x000b7;3</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">50&#x000b7;2</td><td rowspan="1" colspan="1">14&#x000b7;0</td><td rowspan="1" colspan="1">50&#x000b7;6</td><td rowspan="1" colspan="1">14&#x000b7;5</td><td rowspan="1" colspan="1">50&#x000b7;4</td><td rowspan="1" colspan="1">14&#x000b7;5</td><td rowspan="1" colspan="1">49&#x000b7;7</td><td rowspan="1" colspan="1">14&#x000b7;4</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HDL-cholesterol (mmol/l)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0&#x000b7;01</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">1&#x000b7;28</td><td rowspan="1" colspan="1">0&#x000b7;37</td><td rowspan="1" colspan="1">1&#x000b7;34<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;40</td><td rowspan="1" colspan="1">1&#x000b7;28<xref ref-type="table-fn" rid="tfn3_3">&#x02020;</xref></td><td rowspan="1" colspan="1">0&#x000b7;40</td><td rowspan="1" colspan="1">1&#x000b7;29<xref ref-type="table-fn" rid="tfn3_3">&#x02020;</xref></td><td rowspan="1" colspan="1">0&#x000b7;40</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">1&#x000b7;30</td><td rowspan="1" colspan="1">0&#x000b7;36</td><td rowspan="1" colspan="1">1&#x000b7;31</td><td rowspan="1" colspan="1">0&#x000b7;38</td><td rowspan="1" colspan="1">1&#x000b7;30</td><td rowspan="1" colspan="1">0&#x000b7;37</td><td rowspan="1" colspan="1">1&#x000b7;29</td><td rowspan="1" colspan="1">0&#x000b7;37</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="9" rowspan="1">TAG (mg/dl)</td><td rowspan="1" colspan="1">&#x0003c;0&#x000b7;0005</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">126&#x000b7;6</td><td rowspan="1" colspan="1">56&#x000b7;5</td><td rowspan="1" colspan="1">182&#x000b7;9<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">77&#x000b7;9</td><td rowspan="1" colspan="1">223&#x000b7;9<xref ref-type="table-fn" rid="tfn3_2">*</xref><xref ref-type="table-fn" rid="tfn3_3">&#x02020;</xref></td><td rowspan="1" colspan="1">114&#x000b7;4</td><td rowspan="1" colspan="1">209&#x000b7;6<xref ref-type="table-fn" rid="tfn3_2">*</xref><xref ref-type="table-fn" rid="tfn3_4">&#x02021;</xref></td><td rowspan="1" colspan="1">82&#x000b7;9</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">130&#x000b7;1</td><td rowspan="1" colspan="1">70&#x000b7;6</td><td rowspan="1" colspan="1">174&#x000b7;9</td><td rowspan="1" colspan="1">58&#x000b7;2</td><td rowspan="1" colspan="1">265&#x000b7;1</td><td rowspan="1" colspan="1">119&#x000b7;8</td><td rowspan="1" colspan="1">210&#x000b7;4</td><td rowspan="1" colspan="1">111&#x000b7;8</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">TAG (mmol/l)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x0003c;0&#x000b7;0005</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">1&#x000b7;43</td><td rowspan="1" colspan="1">0&#x000b7;64</td><td rowspan="1" colspan="1">2&#x000b7;07<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;88</td><td rowspan="1" colspan="1">2&#x000b7;53<xref ref-type="table-fn" rid="tfn3_2">*</xref><xref ref-type="table-fn" rid="tfn3_3">&#x02020;</xref></td><td rowspan="1" colspan="1">1&#x000b7;29</td><td rowspan="1" colspan="1">2&#x000b7;37<xref ref-type="table-fn" rid="tfn3_2">*</xref><xref ref-type="table-fn" rid="tfn3_4">&#x02021;</xref></td><td rowspan="1" colspan="1">0&#x000b7;94</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">1&#x000b7;47</td><td rowspan="1" colspan="1">0&#x000b7;80</td><td rowspan="1" colspan="1">1&#x000b7;98</td><td rowspan="1" colspan="1">0&#x000b7;66</td><td rowspan="1" colspan="1">3&#x000b7;00</td><td rowspan="1" colspan="1">1&#x000b7;35</td><td rowspan="1" colspan="1">2&#x000b7;38</td><td rowspan="1" colspan="1">1&#x000b7;26</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="9" rowspan="1">Non-HDL-cholesterol (mg/dl)</td><td rowspan="1" colspan="1">0&#x000b7;04</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">145&#x000b7;4</td><td rowspan="1" colspan="1">35&#x000b7;3</td><td rowspan="1" colspan="1">152&#x000b7;6<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">36&#x000b7;5</td><td rowspan="1" colspan="1">152&#x000b7;2<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">36&#x000b7;3</td><td rowspan="1" colspan="1">154&#x000b7;0<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">37&#x000b7;2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">148&#x000b7;5</td><td rowspan="1" colspan="1">34&#x000b7;9</td><td rowspan="1" colspan="1">180&#x000b7;5</td><td rowspan="1" colspan="1">166&#x000b7;6</td><td rowspan="1" colspan="1">157&#x000b7;0</td><td rowspan="1" colspan="1">34&#x000b7;5</td><td rowspan="1" colspan="1">154&#x000b7;0</td><td rowspan="1" colspan="1">33&#x000b7;8</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Non-HDL-cholesterol (mmol/l)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0&#x000b7;04</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">3&#x000b7;77</td><td rowspan="1" colspan="1">0&#x000b7;91</td><td rowspan="1" colspan="1">3&#x000b7;95<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;95</td><td rowspan="1" colspan="1">3&#x000b7;94<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;94</td><td rowspan="1" colspan="1">3&#x000b7;99<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;96</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">3&#x000b7;85</td><td rowspan="1" colspan="1">0&#x000b7;90</td><td rowspan="1" colspan="1">4&#x000b7;67</td><td rowspan="1" colspan="1">4&#x000b7;32</td><td rowspan="1" colspan="1">4&#x000b7;07</td><td rowspan="1" colspan="1">0&#x000b7;89</td><td rowspan="1" colspan="1">3&#x000b7;99</td><td rowspan="1" colspan="1">0&#x000b7;88</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="9" rowspan="1">Insulin (&#x003bc;IU/ml)</td><td rowspan="1" colspan="1">&#x0003c;0&#x000b7;0005</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">14&#x000b7;0</td><td rowspan="1" colspan="1">6&#x000b7;1</td><td rowspan="1" colspan="1">81&#x000b7;7<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">69&#x000b7;3</td><td rowspan="1" colspan="1">34&#x000b7;4<xref ref-type="table-fn" rid="tfn3_2">*</xref><xref ref-type="table-fn" rid="tfn3_3">&#x02020;</xref></td><td rowspan="1" colspan="1">28&#x000b7;6</td><td rowspan="1" colspan="1">Not measured</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">16&#x000b7;4</td><td rowspan="1" colspan="1">10&#x000b7;6</td><td rowspan="1" colspan="1">54&#x000b7;8</td><td rowspan="1" colspan="1">46&#x000b7;1</td><td rowspan="1" colspan="1">39&#x000b7;6</td><td rowspan="1" colspan="1">25&#x000b7;9</td><td rowspan="1" colspan="1">Not measured</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Insulin (pmol/l)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x0003c;0&#x000b7;0005</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">100&#x000b7;7</td><td rowspan="1" colspan="1">44&#x000b7;1</td><td rowspan="1" colspan="1">586&#x000b7;4<xref ref-type="table-fn" rid="tfn3_2">*</xref></td><td rowspan="1" colspan="1">497&#x000b7;4</td><td rowspan="1" colspan="1">246&#x000b7;5<xref ref-type="table-fn" rid="tfn3_2">*</xref><xref ref-type="table-fn" rid="tfn3_3">&#x02020;</xref></td><td rowspan="1" colspan="1">205&#x000b7;5</td><td rowspan="1" colspan="1">Not measured</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">117&#x000b7;5</td><td rowspan="1" colspan="1">75&#x000b7;9</td><td rowspan="1" colspan="1">392&#x000b7;9</td><td rowspan="1" colspan="1">330&#x000b7;4</td><td rowspan="1" colspan="1">283&#x000b7;8</td><td rowspan="1" colspan="1">186&#x000b7;0</td><td rowspan="1" colspan="1">Not measured</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn><p>PO, palm oil; PO&#x000a0;+&#x000a0;MFGM, palm oil&#x000a0;+&#x000a0;milk fat globule membrane.</p></fn><fn id="tfn3_2"><label>*</label><p>Significantly different from 0&#x000a0;h when both treatments analysed together
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn><fn id="tfn3_3"><label>&#x02020;</label><p>Significantly different from 1&#x000a0;h when both treatments analysed together
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn><fn id="tfn3_4"><label>&#x02021;</label><p>Significantly different from 3&#x000a0;h when both treatments analysed together
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn></table-wrap-foot></table-wrap></p><p>The total concentration of each analyte over the 6&#x000a0;h postprandial time was calculated as
the iAUC and compared between test meals. The addition of MFGM to the test meal resulted
in significantly lower concentrations of total cholesterol (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;02 with
all subjects included, <italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;04 with two outliers removed),
LDL-cholesterol (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;046) and a significantly higher concentration of
TAG (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;025) when compared with the PO meal alone (Supplementary Fig.
S1).</p><p>When total insulin concentration was compared over the 6&#x000a0;h postprandial period (i.e. the
iAUC of insulin from 0 to 6&#x000a0;h) the addition of MFGM resulted in a significantly lower
exposure to insulin (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;005) (<xref ref-type="fig" rid="fig02">Fig.
2</xref>). Neither insulin nor glucose concentrations at baseline differed between the two
test meals. There were no effects of treatment on insulin and glucose concentrations in
the postprandial period; however, there was a rapid increase in insulin concentration from
0 to 1&#x000a0;h (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005) that was complemented by a decrease in
glucose (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005). From 1 to 3&#x000a0;h there was an increase back to
baseline levels for glucose (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;003) and a corresponding decrease in
insulin concentrations (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005) although still greater than
the 0&#x000a0;h value (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005). The increase in insulin concentration
was dampened from 0 to 1&#x000a0;h by more than 50&#x000a0;% when MFGM was added to the test meal,
resulting in a 482&#x000a0;% increase <italic>v</italic>. a 234&#x000a0;% increase for PO
<italic>v</italic>. PO&#x000a0;+&#x000a0;MFGM, respectively (time&#x000a0;&#x000d7;&#x000a0;treatment effect,
<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;0005). <fig id="fig02" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p>Postprandial serum insulin concentrations. Serum insulin concentrations over the
6&#x000a0;h postprandial period after a high-fat mixed meal containing palm oil (PO)
<italic>v</italic>. palm oil&#x000a0;+&#x000a0;milk fat globule membrane (PO&#x000a0;+&#x000a0;MFGM). Data are
incremental AUC (iAUC). Values are means, with standard deviations represented by
vertical bars. * The addition of MFGM resulted in a significant decrease of insulin
concentration (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;005).</p></caption><graphic xlink:href="S2048679015000427_fig2"/></fig></p><p>To examine if there was a difference between participants who had high
<italic>v</italic>. low baseline CRP concentrations, additional secondary analyses were
conducted. Participants with baseline CRP concentration &#x02265;3&#x000a0;mg/l (coded as &#x02018;high&#x02019;) had
significantly higher insulin concentrations at 1&#x000a0;h after consuming the PO meal
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;03). The addition of MFGM to the meal suppressed the insulin
response in the high CRP group, thus removing any significant difference between the high
and low CRP groups (<xref ref-type="fig" rid="fig03">Fig. 3</xref>). <fig id="fig03" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p>Insulin concentrations in high (&#x02013;&#x02013;) <italic>v</italic>. low (&#x02013;&#x02013;) baseline
C-reactive protein (CRP) groups. (a) There was a significant difference between the
high and low baseline CRP groups at the 1&#x000a0;h time point (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;03)
after consuming the palm oil meal. (b) When the palm oil&#x000a0;+&#x000a0;milk fat globule membrane
meal was consumed there was no difference between the high and low baseline CRP
groups for insulin. Values are means, with standard deviations represented by
vertical bars. To convert insulin to pmol/l, multiply by 6&#x000b7;945.</p></caption><graphic xlink:href="S2048679015000427_fig3"/></fig></p></sec><sec id="sec2-4"><title>Inflammatory markers</title><p>The two cytokines IL-1&#x003b2; and IL-4 fell below the detection limit for 70 and 95&#x000a0;% of
samples, respectively. Consequently, these markers were not included in the statistical
analyses reported here. Similar results for IL-1&#x003b2; and IL-4 have been observed in previous
studies<sup>(</sup><xref rid="ref41" ref-type="bibr">
<sup>41</sup>
</xref><sup>,</sup><xref rid="ref42" ref-type="bibr">
<sup>42</sup>
</xref><sup>)</sup>.</p><p>Baseline concentrations of all markers related to inflammation were comparable between
the two treatments. When analysed as iAUC, IL-10 was significantly higher
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;013) and sICAM was significantly lower in response to the
PO&#x000a0;+&#x000a0;MFGM test meal (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;005 for all) (<xref ref-type="fig" rid="fig04">Fig. 4</xref>). An interaction effect between time and treatment was observed for IL-10
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;03), IL-8 (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;04) and sICAM
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;02) (<xref ref-type="table" rid="tab04">Table 4</xref>). Over time
IL-10 gradually, but not significantly, declined on the PO treatment whereas on the
PO&#x000a0;+&#x000a0;MFGM treatment IL-10 increased. There was a significant decrease in IL-8 from 0&#x02013;3&#x000a0;h
and 1&#x02013;3&#x000a0;h and a significant increase in concentration from the 3&#x02013;6&#x000a0;h time points
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05 for all) following the PO meal, but IL-8 was unchanged
after the PO&#x000a0;+&#x000a0;MFGM meal. Concentrations for sICAM significantly increased from 0&#x02013;1&#x000a0;h,
0&#x02013;6&#x000a0;h, and 3&#x02013;6&#x000a0;h and significantly decreased between the 1&#x02013;3&#x000a0;h time points
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05 for all) after consumption of the PO meal and, like
IL-8, was unchanged after the PO&#x000a0;+&#x000a0;MFGM challenge. There was no treatment effect observed
for any of the other inflammatory markers, but a significant change over time was observed
for IL-6, IL-8, TNF&#x003b1;, CRP, serum amyloid A, sICAM, soluble vascular adhesion molecule and
cortisol (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05 for all) (<xref ref-type="table" rid="tab04">Table 4</xref>). There was no time or treatment effect for monocyte chemotactic
protein-1. <fig id="fig04" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p>Postprandial serum concentrations of IL-10 (a) and soluble intracellular adhesion
molecule (sICAM) (b). Serum IL-10 and sICAM concentrations over the 6&#x000a0;h postprandial
period after a high-fat mixed meal containing palm oil (PO) <italic>v</italic>. palm
oil&#x000a0;+&#x000a0;milk fat globule membrane (PO&#x000a0;+&#x000a0;MFGM). Data are incremental AUC (iAUC). Values
are means, with standard deviations represented by vertical bars. (a) * The addition
of MFGM resulted in a significant increase of anti-inflammatory IL-10
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;011). (b) * The addition of MFGM resulted in a significant
decrease of sICAM concentration (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;013). The sICAM graph and
data exclude two subjects who were deemed outliers with values more than three box
lengths away from the 75th or 25th percentile.</p></caption><graphic xlink:href="S2048679015000427_fig4"/></fig>
<table-wrap id="tab04" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Concentrations of measured inflammatory markers at each time point</p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679015000427_tab4"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><col align="char" char="&#x000b7;" width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="8" rowspan="1">Time point</th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">0&#x000a0;h</th><th align="center" colspan="2" rowspan="1">1&#x000a0;h</th><th align="center" colspan="2" rowspan="1">3&#x000a0;h</th><th align="center" colspan="2" rowspan="1">6&#x000a0;h</th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Time&#x000a0;&#x000d7;&#x000a0;treatment:
<italic>P</italic></th></tr></thead><tbody><tr><td colspan="10" rowspan="1">IL-10 (pg/ml)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">0&#x000b7;56</td><td rowspan="1" colspan="1">1&#x000b7;35</td><td rowspan="1" colspan="1">0&#x000b7;54</td><td rowspan="1" colspan="1">1&#x000b7;34</td><td rowspan="1" colspan="1">0&#x000b7;54</td><td rowspan="1" colspan="1">1&#x000b7;20</td><td rowspan="1" colspan="1">0&#x000b7;51</td><td rowspan="1" colspan="1">1&#x000b7;30</td><td rowspan="1" colspan="1">0&#x000b7;03</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">0&#x000b7;49</td><td rowspan="1" colspan="1">1&#x000b7;15</td><td rowspan="1" colspan="1">0&#x000b7;52</td><td rowspan="1" colspan="1">1&#x000b7;16</td><td rowspan="1" colspan="1">0&#x000b7;52</td><td rowspan="1" colspan="1">1&#x000b7;09</td><td rowspan="1" colspan="1">0&#x000b7;57</td><td rowspan="1" colspan="1">1&#x000b7;10</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="10" rowspan="1">IL-6 (pg/ml)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">0&#x000b7;74</td><td rowspan="1" colspan="1">1&#x000b7;07</td><td rowspan="1" colspan="1">0&#x000b7;59<xref ref-type="table-fn" rid="tfn4_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;86</td><td rowspan="1" colspan="1">0&#x000b7;61<xref ref-type="table-fn" rid="tfn4_2">*</xref></td><td rowspan="1" colspan="1">1&#x000b7;08</td><td rowspan="1" colspan="1">0&#x000b7;76<xref ref-type="table-fn" rid="tfn4_3">&#x02020;</xref><xref ref-type="table-fn" rid="tfn4_4">&#x02021;</xref></td><td rowspan="1" colspan="1">1&#x000b7;14</td><td rowspan="1" colspan="1">0&#x000b7;48</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">0&#x000b7;72</td><td rowspan="1" colspan="1">1&#x000b7;35</td><td rowspan="1" colspan="1">0&#x000b7;59</td><td rowspan="1" colspan="1">1&#x000b7;23</td><td rowspan="1" colspan="1">0&#x000b7;54</td><td rowspan="1" colspan="1">0&#x000b7;95</td><td rowspan="1" colspan="1">0&#x000b7;76</td><td rowspan="1" colspan="1">1&#x000b7;36</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="10" rowspan="1">IL-8 (pg/ml)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO</td><td rowspan="1" colspan="1">11&#x000b7;24</td><td rowspan="1" colspan="1">3&#x000b7;06</td><td rowspan="1" colspan="1">10&#x000b7;51<xref ref-type="table-fn" rid="tfn4_2">*</xref></td><td rowspan="1" colspan="1">3&#x000b7;30</td><td rowspan="1" colspan="1">9&#x000b7;63<xref ref-type="table-fn" rid="tfn4_2">*</xref></td><td rowspan="1" colspan="1">3&#x000b7;11</td><td rowspan="1" colspan="1">10&#x000b7;96</td><td rowspan="1" colspan="1">2&#x000b7;91</td><td rowspan="1" colspan="1">0&#x000b7;04</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM</td><td rowspan="1" colspan="1">11&#x000b7;11</td><td rowspan="1" colspan="1">3&#x000b7;28</td><td rowspan="1" colspan="1">11&#x000b7;32</td><td rowspan="1" colspan="1">3&#x000b7;23</td><td rowspan="1" colspan="1">10&#x000b7;72</td><td rowspan="1" colspan="1">2&#x000b7;66</td><td rowspan="1" colspan="1">10&#x000b7;8</td><td rowspan="1" colspan="1">3&#x000b7;30</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="10" rowspan="1">TNF&#x003b1; (pg/ml)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">2&#x000b7;49</td><td rowspan="1" colspan="1">0&#x000b7;70</td><td rowspan="1" colspan="1">2&#x000b7;36</td><td rowspan="1" colspan="1">0&#x000b7;56</td><td rowspan="1" colspan="1">2&#x000b7;29</td><td rowspan="1" colspan="1">0&#x000b7;62</td><td rowspan="1" colspan="1">2&#x000b7;36</td><td rowspan="1" colspan="1">0&#x000b7;64</td><td rowspan="1" colspan="1">0&#x000b7;13</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">2&#x000b7;34</td><td rowspan="1" colspan="1">0&#x000b7;66</td><td rowspan="1" colspan="1">2&#x000b7;36</td><td rowspan="1" colspan="1">0&#x000b7;64</td><td rowspan="1" colspan="1">2&#x000b7;27</td><td rowspan="1" colspan="1">0&#x000b7;61</td><td rowspan="1" colspan="1">2&#x000b7;22</td><td rowspan="1" colspan="1">0&#x000b7;66</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="10" rowspan="1">IL-18 (pg/ml)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">145&#x000b7;48</td><td rowspan="1" colspan="1">91&#x000b7;64</td><td rowspan="1" colspan="1">148&#x000b7;44</td><td rowspan="1" colspan="1">75&#x000b7;95</td><td rowspan="1" colspan="1">162&#x000b7;38</td><td rowspan="1" colspan="1">109&#x000b7;73</td><td rowspan="1" colspan="1">150&#x000b7;95</td><td rowspan="1" colspan="1">73&#x000b7;05</td><td rowspan="1" colspan="1">0&#x000b7;59</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">154&#x000b7;25</td><td rowspan="1" colspan="1">83&#x000b7;16</td><td rowspan="1" colspan="1">152&#x000b7;19</td><td rowspan="1" colspan="1">73&#x000b7;41</td><td rowspan="1" colspan="1">155&#x000b7;38</td><td rowspan="1" colspan="1">78&#x000b7;06</td><td rowspan="1" colspan="1">160&#x000b7;03</td><td rowspan="1" colspan="1">72&#x000b7;09</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="10" rowspan="1">MCP-1 (pg/ml)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">345&#x000b7;75</td><td rowspan="1" colspan="1">93&#x000b7;66</td><td rowspan="1" colspan="1">343&#x000b7;23</td><td rowspan="1" colspan="1">104&#x000b7;24</td><td rowspan="1" colspan="1">336&#x000b7;72</td><td rowspan="1" colspan="1">94&#x000b7;82</td><td rowspan="1" colspan="1">330&#x000b7;81</td><td rowspan="1" colspan="1">82&#x000b7;09</td><td rowspan="1" colspan="1">0&#x000b7;26</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">352&#x000b7;16</td><td rowspan="1" colspan="1">84&#x000b7;36</td><td rowspan="1" colspan="1">358&#x000b7;61</td><td rowspan="1" colspan="1">90&#x000b7;41</td><td rowspan="1" colspan="1">320&#x000b7;46</td><td rowspan="1" colspan="1">102&#x000b7;57</td><td rowspan="1" colspan="1">335&#x000b7;05</td><td rowspan="1" colspan="1">97&#x000b7;92</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="10" rowspan="1">CRP (mg/l)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">4&#x000b7;42</td><td rowspan="1" colspan="1">4&#x000b7;69</td><td rowspan="1" colspan="1">4&#x000b7;39</td><td rowspan="1" colspan="1">4&#x000b7;23</td><td rowspan="1" colspan="1">4&#x000b7;42</td><td rowspan="1" colspan="1">4&#x000b7;43</td><td rowspan="1" colspan="1">4&#x000b7;64<xref ref-type="table-fn" rid="tfn4_3">&#x02020;</xref></td><td rowspan="1" colspan="1">4&#x000b7;64</td><td rowspan="1" colspan="1">0&#x000b7;8</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">4&#x000b7;37</td><td rowspan="1" colspan="1">4&#x000b7;29</td><td rowspan="1" colspan="1">5&#x000b7;16</td><td rowspan="1" colspan="1">5&#x000b7;56</td><td rowspan="1" colspan="1">5&#x000b7;11</td><td rowspan="1" colspan="1">5&#x000b7;54</td><td rowspan="1" colspan="1">5&#x000b7;20</td><td rowspan="1" colspan="1">5&#x000b7;38</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="10" rowspan="1">SAA (mg/l)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">3&#x000b7;93</td><td rowspan="1" colspan="1">3&#x000b7;48</td><td rowspan="1" colspan="1">4&#x000b7;04</td><td rowspan="1" colspan="1">3&#x000b7;58</td><td rowspan="1" colspan="1">3&#x000b7;81<xref ref-type="table-fn" rid="tfn4_3">&#x02020;</xref></td><td rowspan="1" colspan="1">3&#x000b7;22</td><td rowspan="1" colspan="1">4&#x000b7;12<xref ref-type="table-fn" rid="tfn4_4">&#x02021;</xref></td><td rowspan="1" colspan="1">3&#x000b7;71</td><td rowspan="1" colspan="1">0&#x000b7;91</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">11&#x000b7;85</td><td rowspan="1" colspan="1">30&#x000b7;79</td><td rowspan="1" colspan="1">12&#x000b7;76</td><td rowspan="1" colspan="1">32&#x000b7;76</td><td rowspan="1" colspan="1">12&#x000b7;20</td><td rowspan="1" colspan="1">31&#x000b7;68</td><td rowspan="1" colspan="1">12&#x000b7;82</td><td rowspan="1" colspan="1">33&#x000b7;37</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="10" rowspan="1">sICAM-1 (mg/l)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">0&#x000b7;97</td><td rowspan="1" colspan="1">0&#x000b7;50</td><td rowspan="1" colspan="1">1&#x000b7;06<xref ref-type="table-fn" rid="tfn4_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;53</td><td rowspan="1" colspan="1">1&#x000b7;00<xref ref-type="table-fn" rid="tfn4_3">&#x02020;</xref></td><td rowspan="1" colspan="1">0&#x000b7;50</td><td rowspan="1" colspan="1">1&#x000b7;04<xref ref-type="table-fn" rid="tfn4_2">*</xref><xref ref-type="table-fn" rid="tfn4_4">&#x02021;</xref></td><td rowspan="1" colspan="1">0&#x000b7;53</td><td rowspan="1" colspan="1">0&#x000b7;02</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">0&#x000b7;96</td><td rowspan="1" colspan="1">0&#x000b7;51</td><td rowspan="1" colspan="1">0&#x000b7;97</td><td rowspan="1" colspan="1">0&#x000b7;50</td><td rowspan="1" colspan="1">0&#x000b7;95</td><td rowspan="1" colspan="1">0&#x000b7;50</td><td rowspan="1" colspan="1">0&#x000b7;97</td><td rowspan="1" colspan="1">0&#x000b7;51</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="10" rowspan="1">sVCAM-1 (mg/l)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">1&#x000b7;55</td><td rowspan="1" colspan="1">0&#x000b7;85</td><td rowspan="1" colspan="1">1&#x000b7;65<xref ref-type="table-fn" rid="tfn4_2">*</xref></td><td rowspan="1" colspan="1">0&#x000b7;86</td><td rowspan="1" colspan="1">1&#x000b7;58<xref ref-type="table-fn" rid="tfn4_3">&#x02020;</xref></td><td rowspan="1" colspan="1">0&#x000b7;86</td><td rowspan="1" colspan="1">1&#x000b7;62<xref ref-type="table-fn" rid="tfn4_4">&#x02021;</xref></td><td rowspan="1" colspan="1">0&#x000b7;86</td><td rowspan="1" colspan="1">0&#x000b7;13</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">1&#x000b7;49</td><td rowspan="1" colspan="1">0&#x000b7;83</td><td rowspan="1" colspan="1">1&#x000b7;51</td><td rowspan="1" colspan="1">0&#x000b7;84</td><td rowspan="1" colspan="1">1&#x000b7;46</td><td rowspan="1" colspan="1">0&#x000b7;82</td><td rowspan="1" colspan="1">1&#x000b7;52</td><td rowspan="1" colspan="1">0&#x000b7;85</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="10" rowspan="1">Cortisol (&#x003bc;g/l)</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO meal</td><td rowspan="1" colspan="1">1139751</td><td rowspan="1" colspan="1">820859</td><td rowspan="1" colspan="1">967108</td><td rowspan="1" colspan="1">659595</td><td align="left" rowspan="1" colspan="1">703305*<xref ref-type="table-fn" rid="tfn4_3">&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">457081</td><td align="left" rowspan="1" colspan="1">653937*<xref ref-type="table-fn" rid="tfn4_3">&#x02020;</xref><xref ref-type="table-fn" rid="tfn4_4">&#x02021;</xref></td><td rowspan="1" colspan="1">577352</td><td rowspan="1" colspan="1">0&#x000b7;76</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;PO&#x000a0;+&#x000a0;MFGM meal</td><td rowspan="1" colspan="1">1083979</td><td rowspan="1" colspan="1">698219</td><td rowspan="1" colspan="1">933085</td><td rowspan="1" colspan="1">619060</td><td rowspan="1" colspan="1">780686</td><td rowspan="1" colspan="1">476281</td><td rowspan="1" colspan="1">613297</td><td rowspan="1" colspan="1">366507</td><td rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn><p>PO, palm oil; PO&#x000a0;+&#x000a0;MFGM, palm oil&#x000a0;+&#x000a0;milk fat globule membrane; MCP-1, monocyte
chemoattractant protein-1; CRP, C-reactive protein; SAA, serum amyloid A; sICAM,
soluble intracellular adhesion molecule; sVCAM, soluble vascular adhesion
molecule.</p></fn><fn id="tfn4_2"><label>*</label><p>Significantly different from 0&#x000a0;h when both treatments analysed together
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn><fn id="tfn4_3"><label>&#x02020;</label><p>Significantly different from 1&#x000a0;h when both treatments analysed together
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn><fn id="tfn4_4"><label>&#x02021;</label><p>Significantly different from 3&#x000a0;h when both treatments analysed together
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></fn></table-wrap-foot></table-wrap></p><p>Secondary analysis using baseline CRP as a covariate revealed a statistically significant
difference for IL-6 at each time point (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05 for each time
point) between participants with high <italic>v</italic>. low baseline CRP concentrations
after consuming the PO test meal. After consuming the PO&#x000a0;+&#x000a0;MFGM test meal, this difference
was no longer significant, suggesting that MFGM may attenuate the postprandial
inflammatory response in individuals with high CRP levels.</p></sec><sec id="sec2-5"><title>Cortisol</title><p>Analysis of serum cortisol revealed no time&#x000a0;&#x000d7;&#x000a0;treatment interaction effect or a treatment
effect. There was a significant decrease in cortisol concentration for all time points
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05 for all time points) over the course of each test day.
Decreases throughout the day, from baseline to 1&#x000a0;h, 1&#x02013;3&#x000a0;h, and 3&#x02013;6&#x000a0;h were as follows: 15,
33 and 43&#x000a0;%, respectively. This observed decrease throughout the day is consistent with
diurnal patterns of cortisol.</p></sec></sec><sec sec-type="discussion" id="sec3"><title>Discussion</title><p>This study was designed to determine if the addition of MFGM to a high-fat meal containing
plant-based saturated fat influences postprandial inflammation in overweight and obese
individuals. Our results showed that adding a dairy fraction rich in MFGM to a high-fat meal
may lower CVD risk by reducing postprandial insulin, total cholesterol and LDL-cholesterol
as well as sICAM concentrations while increasing the concentration of anti-inflammatory
IL-10.</p><p>Compared with PO, consumption of the PO&#x000a0;+&#x000a0;MFGM test meal resulted in a significantly higher
concentration of IL-10 at 6&#x000a0;h postprandial. IL-10 is an anti-inflammatory cytokine which has
been recognised for its atheroprotective effects<sup>(</sup><xref rid="ref43" ref-type="bibr">
<sup>43</sup>
</xref><sup>)</sup>. Our results suggest that the addition of MFGM to a high-SFA meal
improves postprandial inflammation in an overweight and obese population already in a
chronically inflamed state. To our knowledge we are the first to examine the postprandial
effect on IL-10 after a high-fat dietary challenge with and without MFGM in human subjects.</p><p>Cellular adhesion molecules, such as sICAM, are key players in the early events of
atherosclerosis development<sup>(</sup><xref rid="ref44" ref-type="bibr">
<sup>44</sup>
</xref><sup>)</sup>. The consumption of the PO&#x000a0;+&#x000a0;MFGM test meal resulted in a significantly
lower concentration of sICAM over the postprandial period when compared with PO alone. In
large prospective studies of both healthy individuals and patients with CVD, concentrations
of sICAM were positively associated with future incidents of CVD<sup>(</sup><xref rid="ref45" ref-type="bibr">
<sup>45</sup>
</xref><sup>&#x02013;</sup><xref rid="ref47" ref-type="bibr">
<sup>47</sup>
</xref><sup>)</sup>. In our study the total amount of sICAM over the 6&#x000a0;h postprandial period
in response to PO&#x000a0;+&#x000a0;MFGM was significantly lower by 95&#x000a0;% compared with PO. These results
suggest that the addition of a dairy fraction rich in MFGM attenuates the atherogenic milieu
triggered by the PO meal.</p><p>It is possible that the difference in sICAM between the PO <italic>v</italic>. PO&#x000a0;+&#x000a0;MFGM
treatments could stem from the difference in the fatty acid composition. The PO&#x000a0;+&#x000a0;MFGM meal
was higher in short- and medium-chained SFA and lower in 18 : 2<italic>n</italic>-6 and 18 :
1<italic>n</italic>-9 compared with the PO meal. Chen <italic>et
al</italic>.<sup>(</sup><xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref><sup>)</sup> showed that when human retinal vascular endothelial cells were treated
with linoleic acid (18 : 2<italic>n</italic>-6) it resulted in increased ICAM expression.
The MFGM preparation used is composed of complex lipids including sphingolipids, as well as
bioactive proteins, which may also play roles in the observed anti-inflammatory
effects<sup>(</sup><xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref><sup>)</sup>.</p><p>When analysing the insulin iAUC over the 6&#x000a0;h postprandial period, the total insulin
concentration was significantly lower in response to the PO&#x000a0;+&#x000a0;MFGM compared with the PO test
meal. To our knowledge there have not been any prior clinical trials examining the effect of
MFGM consumption on the insulin response in human subjects. One study investigated the
postprandial effect of adding a dairy product rich in sphingolipids, a lipid constituent of
MFGM, to a high-fat breakfast meal and found no significant difference in postprandial
insulin concentrations<sup>(</sup><xref rid="ref50" ref-type="bibr">
<sup>50</sup>
</xref><sup>)</sup>. Branched-chain amino acids may promote insulin
secretion<sup>(</sup><xref rid="ref51" ref-type="bibr">
<sup>51</sup>
</xref><sup>,</sup><xref rid="ref52" ref-type="bibr">
<sup>52</sup>
</xref><sup>)</sup>; thus the effect of MFGM on insulin may be related to its amino acid
composition.</p><p>The secondary analysis based on baseline CRP concentrations revealed that participants who
were in an inflamed state (CRP&#x000a0;&#x02265;&#x000a0;3&#x000a0;mg/l) in the fasted condition had significantly higher
insulin concentrations after consuming the PO meal compared with those who had normal
baseline CRP concentrations. However, the addition of MFGM to the high-fat test meal
completely removed this difference. These results suggest an interaction between diet and
phenotype, whereby consumption of MFGM by chronically inflamed individuals normalised
responses to a high-fat meal to closely resemble that of a metabolically healthy profile.</p><p>Research has shown that cortisol peaks in the morning<sup>(</sup><xref rid="ref53" ref-type="bibr">
<sup>53</sup>
</xref><sup>)</sup>, which was reflected in the present study, and decreases over the course
of the day. Elevated levels of cortisol inhibit the synthesis of pro-inflammatory
cytokines<sup>(</sup><xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref><sup>)</sup>. We hypothesised that this potential inhibition may explain the observed
initial decrease in the pro-inflammatory cytokines (IL-6, IL-8, TNF&#x003b1;) from baseline (blood
draw schedule between 08&#x000b7;00 and 09&#x000b7;00 hours) to the 3&#x000a0;h blood draw (scheduled between 11&#x000b7;00
and 12&#x000b7;00 hours). However, none of the correlations was significant.</p><p>In summary, the addition of a dairy fraction rich in MFGM reduced the iAUC in postprandial
insulin, total cholesterol, LDL-cholesterol and sICAM responses over the 6 h postprandial
period, and increased the production of the anti-inflammatory cytokine IL-10. The addition
of a dairy fraction rich in MFGM also attenuated the increases in insulin at 1&#x000a0;h in
individuals with elevated fasting CRP. Results from this study suggest that the addition of
a dairy fraction rich in MFGM attenuates the negative metabolic and inflammatory effects of
a high-fat meal rich in saturated fat, specifically palmitate.</p></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors would like to thank the study participants for their time and efforts to comply
with the study requirements. The authors thank Fonterra Co-operative Group Ltd (New Zealand)
for supplying the BCP50 product for use in this study. The authors thank the Western Human
Nutrition Research Center kitchen personnel, Dustin Burnett, Sara Dowling and Julie Edwards;
phlebotomist, Jerome Crawford; physiologist, Mary Gustafson; and molecular biologist, Pieter
Oort for their dedication to the project. The US Department of Agriculture is an equal
opportunity employer and provider.</p><p>A. M. Z., J. T. S., J. B. G. and M. D. V. L. designed the research; E. D., N. R., T. S. R.
and E. R. G. conducted the research; E. D. analysed the data; and E. D., A. M. Z., J. T. S.
and M. D. V. L. wrote the paper. E. D. had primary responsibility for the final content. All
authors read and approved the final manuscript.</p><p>M. D. V. L., A. M. Z. and J. T. S. have received research funding from the National Dairy
Council; A. M. Z. received a stipend from the National Dairy Council to present a talk at a
symposium in 2013. The founding sponsors had no role in the design of the study; in the
collection, analyses, or interpretation of the data; in the writing of the manuscript, and
in the decision to publish the results.</p></ack><sec sec-type="supplementary-material" id="sec4"><title>Supplementary material</title><supplementary-material content-type="local-data" id="S2048679015000427sup001"><p>For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/jns.2015.42.</p><media xlink:href="S2048679015000427sup.zip" mimetype="application" mime-subtype="zip" orientation="portrait" id="d36e3558" position="anchor"><caption><p>click here to view supplementary material</p></caption></media></supplementary-material></sec><ref-list id="reflist1"><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Burdge</surname><given-names>GC</given-names></name> &#x00026; <name><surname>Calder</surname><given-names>PC</given-names></name> (<year>2005</year>) <article-title>Plasma cytokine response during the
postprandial period: a potential causal process in vascular disease?</article-title>
<source>Br J Nutr</source>
<volume>93</volume>, <fpage>3&#x02013;9</fpage>.<pub-id pub-id-type="pmid">15705218</pub-id></mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>El Khoury</surname><given-names>D</given-names></name>, <name><surname>Hwalla</surname><given-names>N</given-names></name>, <name><surname>Frochot</surname><given-names>V</given-names></name>, <etal/> (<year>2010</year>) <article-title>Postprandial metabolic and hormonal
responses of obese dyslipidemic subjects with metabolic syndrome to test meals, rich in
carbohydrate, fat or protein</article-title>. <source>Atherosclerosis</source>
<volume>210</volume>, <fpage>307</fpage>&#x02013;<lpage>313</lpage>.<pub-id pub-id-type="pmid">20031131</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Blackburn</surname><given-names>P</given-names></name>, <name><surname>Despr&#x000e9;s</surname><given-names>J-P</given-names></name>, <name><surname>Lamarche</surname><given-names>B</given-names></name>, <etal/> (<year>2006</year>) <article-title>Postprandial variations of plasma
inflammatory markers in abdominally obese men</article-title>. <source>Obesity (Silver
Spring)</source>
<volume>14</volume>, <fpage>1747</fpage>&#x02013;<lpage>1754</lpage>.<pub-id pub-id-type="pmid">17062804</pub-id></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Rector</surname><given-names>RS</given-names></name>, <name><surname>Linden</surname><given-names>Ma</given-names></name>, <name><surname>Zhang</surname><given-names>JQ</given-names></name>, <etal/> (<year>2009</year>) <article-title>Predicting postprandial lipemia in
healthy adults and in at-risk individuals with components of the cardiometabolic
syndrome</article-title>. <source>J Clin Hypertens (Greenwich)</source>
<volume>11</volume>, <fpage>663</fpage>&#x02013;<lpage>671</lpage>.<pub-id pub-id-type="pmid">19878381</pub-id></mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Tushuizen</surname><given-names>ME</given-names></name>, <name><surname>Pouwels</surname><given-names>PJ</given-names></name>, <name><surname>Bontemps</surname><given-names>S</given-names></name>, <etal/> (<year>2010</year>) <article-title>Postprandial lipid and apolipoprotein
responses following three consecutive meals associate with liver fat content in type 2
diabetes and the metabolic syndrome</article-title>. <source>Atherosclerosis</source>
<volume>211</volume>, <fpage>308</fpage>&#x02013;<lpage>314</lpage>.<pub-id pub-id-type="pmid">20227695</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Nappo</surname><given-names>F</given-names></name>, <name><surname>Esposito</surname><given-names>K</given-names></name>, <name><surname>Cioffi</surname><given-names>M</given-names></name>, <etal/> (<year>2002</year>) <article-title>Postprandial endothelial activation in
healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate
meals</article-title>. <source>J Am Coll Cardiol</source>
<volume>39</volume>, <fpage>1145</fpage>&#x02013;<lpage>1150</lpage>.<pub-id pub-id-type="pmid">11923038</pub-id></mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Esposito</surname><given-names>K</given-names></name>, <name><surname>Ciotola</surname><given-names>M</given-names></name>, <name><surname>Sasso</surname><given-names>FC</given-names></name>, <etal/> (<year>2007</year>) <article-title>Effect of a single high-fat meal on
endothelial function in patients with the metabolic syndrome: role of tumor necrosis
factor-&#x003b1;</article-title>. <source>Nutr Metab Cardiovasc Dis</source>
<volume>17</volume>, <fpage>274</fpage>&#x02013;<lpage>279</lpage>.<pub-id pub-id-type="pmid">17134952</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Margioris</surname><given-names>AN</given-names></name> (<year>2009</year>) <article-title>Fatty acids and postprandial
inflammation</article-title>. <source>Curr Opin Clin Nutr Metab Care</source>
<volume>12</volume>, <fpage>129</fpage>&#x02013;<lpage>137</lpage>.<pub-id pub-id-type="pmid">19202384</pub-id></mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>M</given-names></name>, <name><surname>Fleming</surname><given-names>T</given-names></name>, <name><surname>Robinson</surname><given-names>M</given-names></name>, <etal/> (<year>2014</year>) <article-title>Global, regional, and national
prevalence of overweight and obesity in children and adults during 1980&#x02013;2013: a
systematic analysis for the Global Burden of Disease Study 2013</article-title>.
<source>Lancet</source>
<volume>384</volume>, <fpage>766</fpage>&#x02013;<lpage>781</lpage>.<pub-id pub-id-type="pmid">24880830</pub-id></mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Deopurkar</surname><given-names>R</given-names></name>, <name><surname>Ghanim</surname><given-names>H</given-names></name>, <name><surname>Friedman</surname><given-names>J</given-names></name>, <etal/> (<year>2010</year>) <article-title>Differential effects of cream,
glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like
receptor-4 and suppressor of cytokine signaling-3</article-title>. <source>Diabetes Care</source>
<volume>33</volume>, <fpage>991</fpage>&#x02013;<lpage>997</lpage>.<pub-id pub-id-type="pmid">20067961</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Arya</surname><given-names>F</given-names></name>, <name><surname>Egger</surname><given-names>S</given-names></name>, <name><surname>Colquhoun</surname><given-names>D</given-names></name>, <etal/> (<year>2010</year>) <article-title>Differences in postprandial
inflammatory responses to a &#x02018;modern&#x02019; <italic>v.</italic> traditional meat meal: a
preliminary study</article-title>. <source>Br J Nutr</source>
<volume>104</volume>, <fpage>724</fpage>&#x02013;<lpage>728</lpage>.<pub-id pub-id-type="pmid">20377925</pub-id></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Erridge</surname><given-names>C</given-names></name>, <name><surname>Attina</surname><given-names>T</given-names></name>, <name><surname>Spickett</surname><given-names>CM</given-names></name>, <etal/> (<year>2007</year>) <article-title>A high-fat meal induces low-grade
endotoxemia: evidence of a novel mechanism of postprandial inflammation</article-title>.
<source>Am J Clin Nutr</source>
<volume>86</volume>, <fpage>1286</fpage>&#x02013;<lpage>1292</lpage>.<pub-id pub-id-type="pmid">17991637</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Ghanim</surname><given-names>H</given-names></name>, <name><surname>Abuaysheh</surname><given-names>S</given-names></name>, <name><surname>Sia</surname><given-names>CL</given-names></name>, <etal/> (<year>2009</year>) <article-title>Increase in plasma endotoxin
concentrations and the expression of Toll-like receptors and suppressor of cytokine
signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications
for insulin resistance</article-title>. <source>Diabetes Care</source>
<volume>32</volume>, <fpage>2281&#x02013;2287</fpage>.<pub-id pub-id-type="pmid">19755625</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Shah</surname><given-names>M</given-names></name>, <name><surname>Adams-Huet</surname><given-names>B</given-names></name>, <name><surname>Brinkley</surname><given-names>L</given-names></name>, <etal/> (<year>2007</year>) <article-title>Lipid, glycemic, and insulin responses
to meals rich in saturated, <italic>cis</italic>-monounsaturated, and polyunsaturated
(<italic>n</italic>-3 and <italic>n</italic>-6) fatty acids in subjects with type 2
diabetes</article-title>. <source>Diabetes Care</source>
<volume>30</volume>, <fpage>2993</fpage>&#x02013;<lpage>2998</lpage>.<pub-id pub-id-type="pmid">17804680</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Bermudez</surname><given-names>B</given-names></name>, <name><surname>Ortega-Gomez</surname><given-names>A</given-names></name>, <name><surname>Varela</surname><given-names>LM</given-names></name>, <etal/> (<year>2014</year>) <article-title>Clustering effects on postprandial
insulin secretion and sensitivity in response to meals with different fatty acid
compositions</article-title>. <source>Food Funct</source>
<volume>5</volume>, <fpage>1374</fpage>&#x02013;<lpage>1380</lpage>.<pub-id pub-id-type="pmid">24752559</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Teng</surname><given-names>KT</given-names></name>, <name><surname>Chang</surname><given-names>CY</given-names></name>, <name><surname>Chang</surname><given-names>LF</given-names></name>, <etal/> (<year>2014</year>) <article-title>Modulation of obesity-induced
inflammation by dietary fats: mechanisms and clinical evidence</article-title>.
<source>Nutr J</source>
<volume>13</volume>, <fpage>12</fpage>.<pub-id pub-id-type="pmid">24476102</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Hayes</surname><given-names>KC</given-names></name> &#x00026; <name><surname>Pronczuk</surname><given-names>A</given-names></name> (<year>2010</year>) <article-title>Replacing <italic>trans</italic> fat: the
argument for palm oil with a cautionary note on interesterification</article-title>.
<source>J Am Coll Nutr</source>
<volume>29</volume>, <issue>3 Suppl.</issue>,
<fpage>253S</fpage>&#x02013;<lpage>284S</lpage>.<pub-id pub-id-type="pmid">20823487</pub-id></mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Dalbeth</surname><given-names>N</given-names></name>, <name><surname>Gracey</surname><given-names>E</given-names></name>, <name><surname>Pool</surname><given-names>B</given-names></name>, <etal/> (<year>2010</year>) <article-title>Identification of dairy fractions with
anti-inflammatory properties in models of acute gout</article-title>. <source>Ann Rheum
Dis</source>
<volume>69</volume>, <fpage>766</fpage>&#x02013;<lpage>769</lpage>.<pub-id pub-id-type="pmid">19713204</pub-id></mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>EJ</given-names></name>, <name><surname>Suh</surname><given-names>M</given-names></name>, <name><surname>Thomson</surname><given-names>B</given-names></name>, <etal/> (<year>2007</year>) <article-title>Dietary ganglioside inhibits acute
inflammatory signals in intestinal mucosa and blood induced by systemic inflammation of
<italic>Escherichia coli</italic> lipopolysaccharide</article-title>. <source>Shock</source>
<volume>28</volume>, <fpage>112</fpage>&#x02013;<lpage>117</lpage>.<pub-id pub-id-type="pmid">17510604</pub-id></mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Aziz</surname><given-names>MM</given-names></name>, <name><surname>Ishihara</surname><given-names>S</given-names></name>, <name><surname>Mishima</surname><given-names>Y</given-names></name>, <etal/> (<year>2009</year>) <article-title>MFG-E8 attenuates intestinal
inflammation in murine experimental colitis by modulating osteopontin-dependent
alphavbeta3 integrin signaling</article-title>. <source>J Immunol</source>
<volume>182</volume>, <fpage>7222</fpage>&#x02013;<lpage>7232</lpage>.<pub-id pub-id-type="pmid">19454719</pub-id></mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Snow</surname><given-names>DR</given-names></name>, <name><surname>Ward</surname><given-names>RE</given-names></name>, <name><surname>Olsen</surname><given-names>A</given-names></name>, <etal/> (<year>2011</year>) <article-title>Membrane-rich milk fat diet provides
protection against gastrointestinal leakiness in mice treated with
lipopolysaccharide</article-title>. <source>J Dairy Sci</source>
<volume>94</volume>, <fpage>2201</fpage>&#x02013;<lpage>2212</lpage>.<pub-id pub-id-type="pmid">21524510</pub-id></mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Bu</surname><given-names>HF</given-names></name>, <name><surname>Zuo</surname><given-names>XL</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <etal/> (<year>2007</year>) <article-title>Milk fat globule-EGF factor
8/lactadherin plays a crucial role in maintenance and repair of murine intestinal
epithelium</article-title>. <source>J Clin Invest</source>
<volume>117</volume>, <fpage>3673</fpage>&#x02013;<lpage>3683</lpage>.<pub-id pub-id-type="pmid">18008006</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Spitsberg</surname><given-names>VL</given-names></name> (<year>2005</year>) <article-title>Invited review: Bovine milk fat globule
membrane as a potential nutraceutical</article-title>. <source>J Dairy Sci</source>
<volume>88</volume>, <fpage>2289</fpage>&#x02013;<lpage>2294</lpage>.<pub-id pub-id-type="pmid">15956291</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Andersen</surname><given-names>M</given-names></name>, <name><surname>Graversen</surname><given-names>H</given-names></name>, <name><surname>Fedosov</surname><given-names>S</given-names></name>, <etal/> (<year>2000</year>) <article-title>Functional analyses of two cellular
binding domains of bovine lactadherin</article-title>. <source>Biochemistry</source>
<volume>39</volume>, <fpage>6200</fpage>&#x02013;<lpage>6206</lpage>.<pub-id pub-id-type="pmid">10821695</pub-id></mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>El Alwani</surname><given-names>M</given-names></name>, <name><surname>Wu</surname><given-names>BX</given-names></name>, <name><surname>Obeid</surname><given-names>LM</given-names></name>, <etal/> (<year>2006</year>) <article-title>Bioactive sphingolipids in the
modulation of the inflammatory response</article-title>. <source>Pharmacol Ther</source>
<volume>112</volume>, <fpage>171</fpage>&#x02013;<lpage>183</lpage>.<pub-id pub-id-type="pmid">16759708</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Dial</surname><given-names>EJ</given-names></name>, <name><surname>Zayat</surname><given-names>M</given-names></name>, <name><surname>Lopez-Storey</surname><given-names>M</given-names></name>, <etal/> (<year>2008</year>) <article-title>Oral phosphatidylcholine preserves the
gastrointestinal mucosal barrier during LPS-induced inflammation</article-title>.
<source>Shock</source>
<volume>30</volume>, <fpage>729</fpage>&#x02013;<lpage>733</lpage>.<pub-id pub-id-type="pmid">18496240</pub-id></mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Sanchez-Juanes</surname><given-names>F</given-names></name>, <name><surname>Alonso</surname><given-names>J</given-names></name>, <name><surname>Zancada</surname><given-names>L</given-names></name>, <etal/> (<year>2009</year>) <article-title>Glycosphingolipids from bovine milk
and milk fat globule membranes: a comparative study. Adhesion to enterotoxigenic
<italic>Escherichia coli</italic> strains</article-title>. <source>Biol Chem</source>
<volume>390</volume>, <fpage>31</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">18937626</pub-id></mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Dalbeth</surname><given-names>N</given-names></name> &#x00026; <name><surname>Palmano</surname><given-names>K</given-names></name> (<year>2011</year>) <article-title>Effects of dairy intake on hyperuricemia and
gout</article-title>. <source>Curr Rheumatol Rep</source>
<volume>13</volume>, <fpage>132</fpage>&#x02013;<lpage>137</lpage>.<pub-id pub-id-type="pmid">21188562</pub-id></mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Grundy</surname><given-names>SM</given-names></name>, <name><surname>Cleeman</surname><given-names>JI</given-names></name>, <name><surname>Daniels</surname><given-names>SR</given-names></name>, <etal/> (<year>2006</year>) <article-title>Diagnosis and management of the
metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood
Institute scientific statement</article-title>. <source>Curr Opin Cardiol</source>
<volume>21</volume>, <fpage>1</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">16355022</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Pedersen</surname><given-names>A</given-names></name>, <name><surname>Sandstrom</surname><given-names>B</given-names></name> &#x00026; <name><surname>Amelsvoort</surname><given-names>J</given-names></name> (<year>1997</year>) <article-title>The effect of ingestion of inulin on blood
lipids and gastrointestinal symptoms in healthy females</article-title>. <source>Br J
Nutr</source>
<volume>78</volume>, <fpage>215</fpage>&#x02013;<lpage>222</lpage>.<pub-id pub-id-type="pmid">9301412</pub-id></mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="other"><name><surname>Masson</surname><given-names>CJ</given-names></name> &#x00026; <name><surname>Mensink</surname><given-names>RP</given-names></name> (<year>2011</year>) Exchanging saturated fatty acids for (<italic>n</italic>-6)
polyunsaturated fatty acids in a mixed meal may decrease postprandial lipemia and markers
of inflammation and endothelial activity in overweight men. <bold>141</bold>,
<fpage>816</fpage>&#x02013;<lpage>821</lpage>.</mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Fong</surname><given-names>B</given-names></name>, <name><surname>Norris</surname><given-names>C</given-names></name> &#x00026; <name><surname>McJarrow</surname><given-names>P</given-names></name> (<year>2011</year>) <article-title>Liquid chromatography&#x02013;high-resolution
electrostatic ion-trap mass spectrometric analysis of GD3 ganglioside in dairy
products</article-title>. <source>Int Dairy J</source>
<volume>21</volume>, <fpage>42</fpage>&#x02013;<lpage>47</lpage>.</mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>MacKenzie</surname><given-names>A</given-names></name>, <name><surname>Vyssotski</surname><given-names>M</given-names></name> &#x00026; <name><surname>Nekrasov</surname><given-names>E</given-names></name> (<year>2009</year>) <article-title>Quantitative analysis of dairy phospholipids by
<sup>31</sup>P NMR</article-title>. <source>J Am Oil Chem Soc</source>
<volume>86</volume>, <fpage>757</fpage>&#x02013;<lpage>763</lpage>.</mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Guan</surname><given-names>J</given-names></name>, <name><surname>MacGibbon</surname><given-names>A</given-names></name>, <name><surname>Fong</surname><given-names>B</given-names></name>, <etal/> (<year>2015</year>) <article-title>Long term supplementation with &#x003b2; serum
concentrate (BSC), a complex of milk lipids, during post-natal brain development
improves memory in rats</article-title>. <source>Nutrients</source>
<volume>7</volume>, <fpage>4526</fpage>&#x02013;<lpage>4541</lpage>.<pub-id pub-id-type="pmid">26056919</pub-id></mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Fong</surname><given-names>B</given-names></name> &#x00026; <name><surname>Norris</surname><given-names>C</given-names></name> (<year>2009</year>) <article-title>Quantification of milk fat globule membrane
proteins using selected reaction monitoring mass spectrometry</article-title>. <source>J
Agric Food Chem</source>
<volume>57</volume>, <fpage>6021</fpage>&#x02013;<lpage>6028</lpage>.<pub-id pub-id-type="pmid">19537729</pub-id></mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="book"><collab>National Research
Council</collab> (<year>2005</year>) <source>Dietary Reference Intakes for Energy,
Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids
(Macronutrients)</source>. <publisher-loc>Washington, DC</publisher-loc>:
<publisher-name>National Academies Press</publisher-name>.</mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Baecke</surname><given-names>JA</given-names></name>, <name><surname>Burema</surname><given-names>J</given-names></name> &#x00026; <name><surname>Frijters</surname><given-names>JE</given-names></name> (<year>1982</year>) <article-title>A short questionnaire for the measurement of
habitual physical activity in epidemiological studies</article-title>. <source>Am J Clin
Nutr</source>
<volume>36</volume>, <fpage>936</fpage>&#x02013;<lpage>942</lpage>.<pub-id pub-id-type="pmid">7137077</pub-id></mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Matthews</surname><given-names>JN</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Campbell</surname><given-names>MJ</given-names></name>, <etal/> (<year>1990</year>) <article-title>Analysis of serial measurements in
medical research</article-title>. <source>BMJ</source>
<volume>300</volume>, <fpage>230&#x02013;235</fpage>.<pub-id pub-id-type="pmid">2106931</pub-id></mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Carstensen</surname><given-names>M</given-names></name>, <name><surname>Thomsen</surname><given-names>C</given-names></name> &#x00026; <name><surname>Hermansen</surname><given-names>K</given-names></name> (<year>2003</year>) <article-title>Incremental area under response curve more
accurately describes the triglyceride response to an oral fat load in both healthy and
type 2 diabetic subjects</article-title>. <source>Metabolism</source>
<volume>52</volume>, <fpage>1034</fpage>&#x02013;<lpage>1037</lpage>.<pub-id pub-id-type="pmid">12898469</pub-id></mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Pearson</surname><given-names>TA</given-names></name> (<year>2003</year>) <article-title>Markers of inflammation and cardiovascular
disease: application to clinical and public health practice: a statement for healthcare
professionals from the Centers for Disease Control and Prevention and the American Heart
Association</article-title>. <source>Circulation</source>
<volume>107</volume>, <fpage>499</fpage>&#x02013;<lpage>511</lpage>.<pub-id pub-id-type="pmid">12551878</pub-id></mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Kleiner</surname><given-names>G</given-names></name>, <name><surname>Marcuzzi</surname><given-names>A</given-names></name>, <name><surname>Zanin</surname><given-names>V</given-names></name>, <etal/> (<year>2013</year>) <article-title>Cytokine levels in the serum of
healthy subjects</article-title>. <source>Mediators Inflamm</source>
<volume>2013</volume>, <fpage>434010</fpage>.<pub-id pub-id-type="pmid">23533306</pub-id></mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Rosenberg-Hasson</surname><given-names>Y</given-names></name>, <name><surname>Hansmann</surname><given-names>L</given-names></name>, <name><surname>Liedtke</surname><given-names>M</given-names></name>, <etal/> (<year>2014</year>) <article-title>Effects of serum and plasma matrices
on multiplex immunoassays</article-title>. <source>Immunol Res</source>
<volume>58</volume>, <fpage>224</fpage>&#x02013;<lpage>233</lpage>.<pub-id pub-id-type="pmid">24522699</pub-id></mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>X</given-names></name> &#x00026; <name><surname>Boisvert</surname><given-names>WA</given-names></name> (<year>2012</year>) <article-title>The role of IL-10 in
atherosclerosis</article-title>. In <source>Atherogenesis</source>, pp.
<fpage>361</fpage>&#x02013;<lpage>384</lpage> [<string-name>
<given-names>S</given-names>
<surname>Parthasarathy</surname>
</string-name>, editor]. <uri xlink:type="simple" xlink:href="http://cdn.intechopen.com/pdfs-wm/25913.pdf">http://cdn.intechopen.com/pdfs-wm/25913.pdf</uri> (accessed
<date-in-citation content-type="access-date">January
2016</date-in-citation>).</mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Blankenberg</surname><given-names>S</given-names></name>, <name><surname>Barbaux</surname><given-names>S</given-names></name> &#x00026; <name><surname>Tiret</surname><given-names>L</given-names></name> (<year>2003</year>) <article-title>Adhesion molecules and
atherosclerosis</article-title>. <source>Atherosclerosis</source>
<volume>170</volume>, <fpage>191</fpage>&#x02013;<lpage>203</lpage>.<pub-id pub-id-type="pmid">14612198</pub-id></mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Ridker</surname><given-names>PM</given-names></name>, <name><surname>Hennekens</surname><given-names>CH</given-names></name>, <name><surname>Roitman-Johnson</surname><given-names>B</given-names></name>, <etal/> (<year>1998</year>) <article-title>Plasma concentration of soluble
intercellular adhesion molecule 1 and risks of future myocardial infarction in
apparently healthy men</article-title>. <source>Lancet</source>
<volume>351</volume>, <fpage>88</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">9439492</pub-id></mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>Ridker</surname><given-names>P</given-names></name>, <name><surname>Hennekens</surname><given-names>C</given-names></name>, <name><surname>Buring</surname><given-names>J</given-names></name>, <etal/> (<year>2000</year>) <article-title>C-reactive protein and other markers
of inflammation in the prediction of cardiovascular disease in women</article-title>.
<source>New Engl J Med</source>
<volume>342</volume>, <fpage>836</fpage>&#x02013;<lpage>843</lpage>.<pub-id pub-id-type="pmid">10733371</pub-id></mixed-citation></ref><ref id="ref47"><label>47.</label><mixed-citation publication-type="journal"><name><surname>Tanne</surname><given-names>D</given-names></name>, <name><surname>Haim</surname><given-names>M</given-names></name>, <name><surname>Boyko</surname><given-names>V</given-names></name>, <etal/> (<year>2002</year>) <article-title>Soluble intercellular adhesion
molecule-1 and risk of future ischemic stroke: a nested case&#x02013;control study from the
Bezafibrate Infarction Prevention (BIP) Study cohort</article-title>. <source>Stroke</source>
<volume>33</volume>, <fpage>2182</fpage>&#x02013;<lpage>2186</lpage>.<pub-id pub-id-type="pmid">12215584</pub-id></mixed-citation></ref><ref id="ref48"><label>48.</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>W</given-names></name>, <name><surname>Jump</surname><given-names>DB</given-names></name>, <name><surname>Grant</surname><given-names>MB</given-names></name>, <etal/> (<year>2003</year>) <article-title>Dyslipidemia, but not hyperglycemia,
induces inflammatory adhesion molecules in human retinal vascular endothelial
cells</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<volume>44</volume>, <fpage>5016</fpage>&#x02013;<lpage>5022</lpage>.<pub-id pub-id-type="pmid">14578429</pub-id></mixed-citation></ref><ref id="ref49"><label>49.</label><mixed-citation publication-type="journal"><name><surname>Contarini</surname><given-names>G</given-names></name> &#x00026; <name><surname>Povolo</surname><given-names>M</given-names></name> (<year>2013</year>) <article-title>Phospholipids in milk fat: composition,
biological and technological significance, and analytical strategies</article-title>.
<source>Int J Mol Sci</source>
<volume>14</volume>, <fpage>2808</fpage>&#x02013;<lpage>2831</lpage>.<pub-id pub-id-type="pmid">23434649</pub-id></mixed-citation></ref><ref id="ref50"><label>50.</label><mixed-citation publication-type="journal"><name><surname>Ohlsson</surname><given-names>L</given-names></name>, <name><surname>Burling</surname><given-names>H</given-names></name>, <name><surname>Duan</surname><given-names>R-D</given-names></name>, <etal/> (<year>2010</year>) <article-title>Effects of a sphingolipid-enriched
dairy formulation on postprandial lipid concentrations</article-title>. <source>Eur J
Clin Nutr</source>
<volume>64</volume>, <fpage>1344</fpage>&#x02013;<lpage>1349</lpage>.<pub-id pub-id-type="pmid">20808331</pub-id></mixed-citation></ref><ref id="ref51"><label>51.</label><mixed-citation publication-type="journal"><name><surname>Rietman</surname><given-names>A</given-names></name>, <name><surname>Schwarz</surname><given-names>J</given-names></name>, <name><surname>Tom&#x000e9;</surname><given-names>D</given-names></name>, <etal/> (<year>2014</year>) <article-title>High dietary protein intake, reducing
or eliciting insulin resistance?</article-title>
<source>Eur J Clin Nutr</source>
<volume>68</volume>, <fpage>973</fpage>&#x02013;<lpage>979</lpage>.<pub-id pub-id-type="pmid">24986822</pub-id></mixed-citation></ref><ref id="ref52"><label>52.</label><mixed-citation publication-type="journal"><name><surname>Dugan</surname><given-names>CE</given-names></name> &#x00026; <name><surname>Fernandez</surname><given-names>ML</given-names></name> (<year>2014</year>) <article-title>Effects of dairy on metabolic syndrome
parameters: a review</article-title>. <source>Yale J Biol Med</source>
<volume>87</volume>, <fpage>135</fpage>&#x02013;<lpage>147</lpage>.<pub-id pub-id-type="pmid">24910559</pub-id></mixed-citation></ref><ref id="ref53"><label>53.</label><mixed-citation publication-type="book"><name><surname>Van Cauter</surname><given-names>E</given-names></name> &#x00026; <name><surname>Aschoff</surname><given-names>J</given-names></name> (<year>1989</year>) <chapter-title>Endocrine and other biological
rhythms</chapter-title> In <source>Endocrinology</source>, <edition>3rd ed.</edition>,
pp. <fpage>2658</fpage>&#x02013;<lpage>2705</lpage> [<string-name>
<given-names>LJ</given-names>
<surname>DeGroot</surname>
</string-name>, editor]. <publisher-loc>Philadelphia, PA</publisher-loc>:
<publisher-name>Saunders</publisher-name>.</mixed-citation></ref><ref id="ref54"><label>54.</label><mixed-citation publication-type="journal"><name><surname>Swolin-Eide</surname><given-names>D</given-names></name> &#x00026; <name><surname>Ohlsson</surname><given-names>C</given-names></name> (<year>1998</year>) <article-title>Effects of cortisol on the expression of
interleukin-6 and interleukin-1&#x003b2; in human osteoblast-like cells</article-title>.
<source>J Endocrinol</source>
<volume>156</volume>, <fpage>107</fpage>&#x02013;<lpage>114</lpage>.<pub-id pub-id-type="pmid">9496240</pub-id></mixed-citation></ref></ref-list></back></article>